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ABSTRACT
The early onset epileptic encephalopathy of infantile spasms is frequently associated with 
acute cognitive regression, long-term learning disability and autistic spectrum disorder. 
Although there may be a structural basis to the epilepsy, it appears that seizure activity is 
directly implicated in the process associated with the above disabilities. There are strong 
indications of the crucial role of temporal lobe dysfunction in children within this and 
related epileptic regressions; including the site of lesions in tuberous sclerosis and the EEG 
localisation in a later onset epileptic encephalopathy, the Landau-Kleffner-syndrome. Thus 
the hypothesis for this study was that the temporal lobe is functionally abnormal in children 
with infantile spasms. This was tested by recording event related potentials, the electrical 
indicators of the brain’s perception and processing of auditory stimuli. The aims of the 
current study were to describe the normal developmental changes of mismatch-negativity 
(MMN) and novelty P3 in the first year of life and to identify whether these ERPs are 
abnormal in children with infantile spasms. The developmental status of infants with 
infantile spasms was assessed at presentation.
The MMN was only shown in a group mean average in control infants. All obligatory and 
the endogenous P250, P500, Ncl and Nc2 ERP components of the control infants showed 
age dependent latencies and differed in latency between wakefulness and stage 2 sleep. 
Using nonparametric calculations infants with infantile spasms had prolonged latencies of 
the obligatory and endogenous components during both wakefulness and sleep compared to 
controls.
The results of this study support the hypothesis that the auditory processing is interrupted in 
infants with infantile spasms. As the auditory cortex is very immature during the first year 
of life it is therefore suggested that infantile spasms may interfere with crucial maturational 
processes during the first year of life.
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CHAPTER 1: INTRODUCTION
1.1. Epileptic encephalopathies
1.1.1. Definition of epilepsy and epileptic encephalopathy
Epilepsy is defined as a chronic condition, characterized by recurrent epileptic seizures, 
which are clinical events associated with hypersynchronous, usually self-limited, activity of 
neurons in the brain (Blume et al., 2001). Epilepsy is the most common potentially treatable 
serious neurological disorder in children and young adults affecting 1-2 % of the total 
population (Hauser, 1990) and 4% of children (Hauser, 1995). The incidence of epilepsy is 
greatest in the first year of life, remains high up to 4 years of age, falls during childhood and 
declines more slowly during adolescence and adult life with a second peak in older people.
Children with epilepsy have more behavioural and cognitive problems than children with 
other non neurological chronic illnesses and children in the general population (Dunn et al.,
1999). They are also more likely to suffer from a psychiatric disorder than children in the 
general population or even those with other types of chronic illness (Davies et al., 2003). 
Further problems faced by children with epilepsy include educational underachievement 
and unemployment in adulthood (Aldenkamp et al., 1990; Sillanpaa, 1990; Sillanpaa,
2004).
A severe global cognitive deterioration can occur in infants and young children, in whom 
frequent seizure activity and subclinical interictal activity may cause a general nervous 
system dysfunction: a condition referred to as an “epileptic encephalopathy” (EE). The 
international league against epilepsy (ILAE) has defined epileptic encephalopathy as a 
condition in which epileptic abnormalities are believed to contribute to the progressive 
disturbance in cerebral function (Engel, 2001). Several epileptic syndromes, defined as
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discreet epilepsy conditions with a complex of clinical and neurophysiological features 
(Blume et al, 2001), including, Ohtahara syndome, West syndrome, Dravet syndrome or 
severe myoclonic epilepsy of infancy, Lennox-Gastaut syndrome, the Landau- Kleffner 
syndrome and epilepsy with continuous spike-waves during slow wave sleep (CSWS) are 
included in this definition. Early EEs have 4 common features: they begin during infancy or 
childhood, there is high rate of epileptic discharges, they are often refractory to antiepileptic 
drugs (AEDs) and there is frequently a poor developmental outcome. All domains of 
functioning including cognitive, behavioural and motor domains may be affected. Whilst 
early epileptic encephalopathies have severe cognitive impairment in common, each has its 
own characteristic clinical features (Wirrell et al., 2005). This study investigated the 
pathogenesis of these impairments in the most common early onset epilepsy syndrome of 
infantile spasms.
1.1.1.1. Experimental evidence in animals for seizure induced cognitive impairment 
Experimental evidence from animal models has shown that the developing immature brain 
differs from the adult brain in its susceptibility to seizures, seizure characteristics and 
responses to AEDs (Holmes, 1997). Compared to the adult brain the immature brain 
appears to be relatively resistant to seizure induced neuronal injury (Sperber, 1996; Holmes, 
1997). Although there is less histological evidence of damaged neurons in the immature 
brain, there is increasing evidence that seizures may alter the function of surviving neurons 
and neuronal circuitry to reduce seizure thresholds permanently or promote epileptogenesis 
(Jensen et al., 1992; Anderson et al., 1997; Jensen et al, 1998; Anderson et al., 1999; Chen 
et al, 1999). Animals subjected to repeated seizures in early life show significant 
impairments in learning and memory in adulthood (Huang et al., 1999). The cellular and 
molecular changes associated with these functional changes are still under investigation. 
However the experimental findings to date reinforce the concept that seizures can induce 
long-lasting functional changes in the brain (Huang et al., 1999), which may not appear 
acutely as injury (Holmes, 1997).
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1.1.1.2. Early onset EEs
Early onset EEs are associated with a high rate of cognitive and social impairments. Three 
retrospective hospital-based studies of outcome from all epilepsies starting in the first year 
of life have shown mortality to be higher and severe learning disability to be more common 
in patients with infantile spasms (IS) than in those with febrile seizures, generalised or 
partial seizures or status epilepticus (Chevrie et al., 1978; Cavazzuti et al., 1984; Dalla et 
al., 1982). In all three series, factors associated with poor prognosis included a symptomatic 
cause for the epilepsy and early onset (before the age of 6 months). In a population based 
retrospective study looking at outcome of seizures occurring in the first years of life, 53% 
of 40 infants had developmental delay and 50% had abnormal neurological examinations at 
follow-up. Seizure onset less than 3 months of age, infantile spasms, abnormal neurological 
examination and epileptic discharges in the EEG at presentation, poor seizure-control and 
use of more than one AEDS were predictors of uncontrolled epilepsy at follow-up (Datta et 
al., 2000).
1.1.1.3. Models of epileptic encephalopathy
In epileptic encephalopathies the outcome may not necessarily be related to the severity of 
the clinical seizures, but to the ongoing subclinical epileptic activity. Before describing the 
syndrome of infantile spasms in some detail, two other epileptic encephalopathies are 
briefly described to illustrate the effect of continuing subclinical and clinical epileptic 
activity on the cognitive development in childhood.
1.1.1.3.1. The Landau-Kleffner-Syndrome
The strongest evidence for subclinical epileptic activity causing an encephalopapthy comes 
from a later onset EE, the acquired epilepsy-aphasia syndrome (also called the Landau- 
Kleffner Syndrome). This epilepsy syndrome usually presents between 3 and 7 years of age 
(Neville et al., 2006) and is characterized by an acquired aphasia, paroxysmal EEG
27
abnormalities, seizures and the absence of a focal brain lesion (Deonna et al., 1995). The 
onset of this acquired epileptic aphasia is variable, most often subacute, or progressive and 
with spontaneous fluctuations (Deonna et al., 1995). The type of aphasia seen is typically a 
verbal auditory agnosia (Rapin et al., 1977) but all types of aphasia can occur (Chevrie- 
Mueller et al., 1991). Additional impairments may include attention deficit/ hyperactivity, 
motor organization problems and features of autistic spectrum disorder (Neville et al., 1998; 
Neville et al., 2000). Approximately seventy percent of patients present with seizures, 
which are generally easily controlled (Neville et al., 2006). However EEG findings are by 
definition consistently abnormal in LKS, regardless of the occurrence of seizures 
(Beaumanoir, 1992). Most common are centrotemporoparietal discharges consisting of slow 
waves, spikes and spike-wave discharges (Beaumanoir, 1992). In most patients with LKS 
these epileptiform abnormalities increase during sleep amounting to continuous spike and 
wave pattern occupying between 50-85% of slow wave sleep (CSWS). In the thirty percent 
of patients without clinical seizures at presentation, the language and cognitive impairment 
may be explained on the basis of these continuous subclinical high rates of discharges in 
sleep (Beaumanoir, 1992). The continuous subclinical discharges may also be associated 
with atrophic changes in the temporal lobes. The superior temporal areas (planum temporale 
and superior temporal areas) in children with Landau-Kleffner Syndrome were smaller 
compared to children with partial focal seizures. None of the patients within the study had 
frequent seizures, but all had very active epileptiform activity (three out of four patients had 
the EEG pattern continuous spike-wave in slow wave sleep) which may have caused the 
atrophic changes of the temporal lobes (Takeoka et al., 2004), but currently no longitudinal 
data exist. While the continuous epileptiform activity may cause structural damage to the 
temporal lobes, it could also cause functional damage by affecting the processing of 
language. Auditory long latency evoked responses time-locked to the interictal spikes were 
associated with a greater reduction in amplitude and increase in latency over the left 
hemisphere than over the right hemisphere (Seri et al., 1998).
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The frequency and type of seizures do not affect the outcome and the prognosis and 
outcome of LKS are very unpredictable (Loonen et al., 1990; Beaumanoir, 1992). An early 
onset before five years of age, persisting temporal EEG abnormalities and the duration in 
terms of years of CSWS seem to be associated with an unfavourable outcome (Tassinari et 
al, 2002).
1.1.1.3.2. Gelastic seizures in association with hypothalamic hamartoma 
Gelastic seizures are characterised by frequent, repeated attacks of unnatural mirthless 
laughter (Kerrigan et al., 2005). If gelastic seizures are associated with a hypothalamic 
hamartoma they may provide a further model of an epileptic encephalopathy, although 
“hypothalamic gelastic epilepsy” is not recognized as a separate syndrome in the ILAE 
classification of 2001 (Engel, 2001). Nevertheless the association between hypothalamic 
hamartoma, precocious puberty and gelastic seizures is well established (Deonna et al.,
2000). This form of epilepsy, often refractory to conventional AEDs, appears to be 
extremely rare, is characterised by sudden episodes of inappropriate laughter and a peak 
seizure frequency at around 2-3 years of age. Most children have an arrest in their 
development with major behavioural problems coinciding with the onset of epilepsy 
(Deonna et al., 2000). Out of 67 cases, 52 were reported to be cognitively and behaviourally 
abnormal, but no details of the cognitive and behavioural problems were given (Deonna et 
al., 2000). There is evidence from invasive monitoring that the hamartoma is the origin of 
the gelastic seizures with secondary spread to the frontal and temporal cortex (Munari et al., 
1995). Therefore, the acquired cognitive arrest and behavioural symptoms in these children 
are most likely to result from the direct effect of seizure activity, because children with 
hypothalamic hamartomas and precocious puberty, but without seizures, do not present 
cognitive and behavioural problems (Stewart et al., 1998).
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1.1.2. The encephalopathy of infantile spasms/West syndrome
1.1.2.1. Incidence, onset and clinical presentation of infantile spasms 
The most common early onset EE is the syndrome of infantile spasms (IS) or West 
syndrome, which has an estimated incidence at between 0.25 and 0.60 per 1000 live births 
per year. The reported prevalence rate ranges from 0.14 to 0.52 per 1000 children, with an 
average of 0.25 per 1000 children (Hrachovy et al., 2003). IS show a strong age dependence 
and begin almost exclusively during the first year of life, with a maximum incidence 
between 3 and 7 months of age. This age related encephalopathy combines paroxysmal 
events of different types of spasms (spasms in clusters), psychomotor deterioration and 
diffuse and nearly continuous paroxysmal activity in the EEG, with hypsarrhythmia being 
the most characteristic pattern. The term West Syndrome is synonymous with IS and recalls 
the original description of IS by Dr William West in his own son in 1841(West, 1840).
More boys are affected than girls. The range of aetiologies associated with IS is large and 
includes neurocutaneous syndromes, brain malformations and various diffuse, prenatal or 
acquired encephalopathies (Watanabe, 1998). As a general rule any early process affecting 
brain development can cause IS. An important cause is tuberous sclerosis (Pampiglione et 
al., 1975; Hunt, 1983; Curatolo et al., 2001) in which IS are common and where outcome in 
those with early onset spasms is usually poor, with global developmental delay and autistic 
features seen in 60 % (Shepherd et al., 1995).
Infantile spasms are traditionally divided into cases of symptomatic origin versus those of 
non-symptomatic (cryptogenic) origin. Patients with normal prior development, no known 
causal factors and those with normal imaging may be categorized as cryptogenic (“hidden 
lesions”). In the past, the number of reported patients with cryptogenic designation has 
ranged from as low as 6% to as high as 66% (Hrachovy et al., 2003). These differences are 
heavily dependent on the extent of the investigations performed and improvement in 
diagnostic imaging techniques. Although IS are frequently associated with poor 
neurodevelopmental outcome, it has been suggested that there is a truly idiopathic form
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with normal outcome (Dulac et al, 1993; Vigevano et al., 1993) This idiopathic group may 
be recognized at the onset as these infants show no mental regression, preserved visual 
behaviour, absence of focal interictal EEG abnormality after intravenous diazepam and 
reappearance of hypsarrhythmia between consecutive spasms of a cluster (Dulac et al, 
1993). However, predicting normal outcome using ictal EEG characteristics was not 
confirmed by Haga and colleagues, who found no significant difference between patients 
with persistence or reappearance of hypsarrhythmia and the patients without 
hypsarrhythmia between episodes of spasms. On the contrary several patients with IS 
without hypsarrhythmia re-occurring between spasms had a good outcome (Haga et al, 
1995). The pathophysiological mechanisms generating the possible reappearance of 
hypsarrhythmia are not known. Therefore, the criteria by Dulac et al (1993) have not been 
widely replicated and further work in this area is required before the findings can be reliably 
translated into clinical practice. In this study we will only differentiate between 
symptomatic and cryptogenic patients.
1.1.2.2. Diagnosis and current methods of assessment
The diagnosis of the syndrome of IS is based upon the clinical history and examination, 
supported by neurophysiological data. Characteristic spasms and an abnormal EEG are 
essential for the diagnosis. There may be abnormal development prior to the onset of 
spasms, regression with continuing spasms but in a small group development both before 
the onset of spasms and during the course of the spasms remains normal. Recommended 
initial investigations include an EEG, skin examination including ultraviolet light for 
possible hypopigmented skin patches in tuberous sclerosis and magnetic resonance imaging 
(MRI) of the brain. As metabolic and acute infections are uncommon causes for IS further 
metabolic investigations and cerebrospinal fluid analysis are usually carried out as a second 
stage if there is sufficient clinical suspicion of such an underlying pathology and if other 
investigations are normal. Ophthalmologic examination may in rare cases suggest the 
underlying aetiology, as for example in Aicardi syndrome and in congenital infections. A
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retrospective study examining the effectiveness of using such a stepwise diagnostic 
evaluation for infantile spasms supports the above approach (Trasmonte et al., 1998).
1.1.2.2.1. Seizures
IS (Kellaway et al., 1979b; Dulac et al., 1994) are characterised by sudden bilateral 
symmetrical contraction of muscles of the neck, trunk and extremities. The type of seizure 
depends on whether the flexor or extensor muscles are predominantly affected and on the 
extent of the contraction. Mixed flexor/extensor spasms, accounting for 50 % of the cases, 
are the most common type. These consist either of flexion of the neck, trunk and elbows 
with knee extension or, less commonly, of flexion at the hips with knee extension and 
elbow extension with varying degrees of flexion of the neck and trunk and are dependent on 
the child’s resting position when the spasms supervened. Spasms may be also asymmetrical, 
and these are often associated with a symptomatic aetiology in particular with unilateral 
lesions, although such lesions may also be associated with symmetrical attacks. The spasms 
occur in repetitive series (clusters) in which each attack is brief, lasting only seconds and 
occurring at intervals of 5-40 seconds. Infants may have ten to hundreds of spasms daily 
and the number of spasms is often vastly in excess of what parents report (Kellaway et al., 
1979a; Gaily et al., 2001). The repetitive character of the spasms is a very important 
diagnostic clue. A cry is common at the time of, or just after each spasm. In young infants, 
atypical presentations (head nodding, eye elevation, movement of one limb) occurring 
repetitively might be the only clue to the diagnosis of infantile spasms. A variety of clinical 
phenomena such as respiratory rate changes, abnormal eye movements (nystagmus, eye 
opening or closing), smiling and grimacing have been reported to occur in association with 
the spasms. Clusters may occur in sleep, but tend to occur more frequently at the time of 
awakening or at the transition from slow to REM sleep (Plouin et al., 1987). Clusters are 
also frequent during drowsiness. They are not precipitated by any obvious stimulus (Plouin 
etal,  1987).
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7.7.2.2.2. EEG
The most common EEG pattern observed in children with IS is hypsarrhythmia (Cowan et 
al., 1991; Jeavons et al, 1992), although this is not the sole EEG finding. Gibbs and Gibbs 
(1952) defined hypsarrhythmia as an EEG consisting of “very high voltage, random, slow 
waves and spikes in all cortical areas (Gibbs et al., 1952).The spikes vary from moment to 
moment in duration and location, at times they seem to be focal in one part of the cortex, 
and a few seconds later they seem to come from another focus, or possibly from multiple 
foci. The chaotic appearance of this abnormality gives the impression of a nearly total 
disorganization of cortical voltage regulation”. Overall 40-70 % of children show 
hypsarrhythmia, but in patients with tuberous sclerosis and infantile spasms only 22 % 
showed hypsarrhythmia (Gomez et al., 1999).
In many patients atypical forms of hypsarrhythmia are seen (Hrachovy et al., 1984). One of 
the more common variants is asymmetrical hypsarrhythmia, which refers to a 
hypsarrhythmic EEG in which there are consistent voltage asymmetries between the two 
sides. This may be associated with underlying structural abnormalities of the brain 
(Hrachovy et al., 1984; Watanabe et al., 1993). The interictal pattern of hypsarrhythmia is 
seen more frequently in NREM sleep than in wakefulness or arousal. In REM sleep 
hypsarrhythmia is not observed. The continuity of the paroxysmal discharges also changes 
with states of awareness and is greatest in wakefulness and stage 1 but decreases with stage 
2-3 (Watanabe et al., 1993).
Several attempts have been made to correlate the severity of hypsarrhythmia with outcome 
(Rating et al., 1987; Kramer et al., 1997). It has been suggested that a favourable outcome 
is associated with the classical symmetrical hypsarrhythmia evolving to either both focal 
epileptogenic activity or symmetrical sleep spindles or to a normal EEG. By contrast a 
grossly asymmetric hypsarrhythmia is associated with poor outcome (Saltik et al., 2002). 
Different scoring protocols for the severity of hypsarrhythmia, failure to distinguish
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between findings in sleep and wakefulness, failure to distinguish findings before or after 
treatment and imprecise descriptions of cognitive outcome make comparison of the 
published studies difficult. Therefore no scoring protocol has been adopted for routine 
clinical assessment in individual patients.
The ictal EEG pattern corresponding to spasms is variable (Kellaway et al., 1979c). The 
most characteristic ictal EEG patterns are a positive wave over the vertex-central region, 
spindle-like medium amplitude fast activity and diffuse flattening called decremental 
activity (Fusco et al., 1993). Correlating clinical manifestations and ictal EEG in 36 
patient’s video-EEG and polygraphic recordings showed the slow wave to be always 
present and corresponding to the clincal spasms. The fast activity occurred either alone or 
was followed by the slow wave and never corresponded to a clinical spasms. When there 
was only fast activity, the main clinical feature associated was a motionless stare and this 
tended to occur either at the beginning or the end of a cluster. The decremental activity was 
rare and always followed the slow wave and clinical spasms, but was never accompanied by 
clear behavioural events (Fusco et al., 1993). The reported frequency of fast beta activity 
was 17.5 Hz (Panzica et al., 1999) preceding a cluster of spasms or 14-16 Hz (Fusco et al., 
1993) at the end of a cluster of spasms. The reported frequency within the gamma band was 
50-100 Hz during the middle part of a cluster of spasms (Kobayashi et al., 2004).
1.1.2.2.3. Mental Deterioration
Mental deterioration may precede, coincide with, or follow the onset of spasms (Gastaut et 
a l ., 1964b, Jeavons and Bower , 1964). In a small number of children, cognitive 
development may remain normal (Jeavons et al., 1973). In many children there is a definite 
behavioural regression that occurs in previously well infants, with regression of vocal 
production and loss of visual interest. The infants may not turn their head towards visual 
stimuli and lack visual responsiveness. There may be a complete loss of social 
communication. They may no longer take notice of people and lose responsive smiling.
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Loss of eye tracking and smiling in infants with IS appear to be prognostic indicators of the 
poor mental outcome seen in most children (Dulac et al, 1993; Jambaque et al., 1993). A 
prospective study in children with perinatal brain injury showed that most of those who 
subsequently developed West syndrome lost previously acquired visual and cognitive 
abilities. Abnormal visual attentiveness was still present after the acute phase of the 
syndrome at the age of 2 years (Guzzetta et al, 2002). Motor regression is usually less 
profound, but voluntary reaching and grasping often disappear (O'Donohoe, 1985).
1.1.2.3. Outcome
The prognosis for IS is poor with cognitive impairment in 71-90% of children and a 
mortality of between 5 and 30% (Riikonen, 1996; Trevathan et al., 1999; Wong et al.,
2001). In 30% to 50 % of patients visual, auditory and motor deficits are present in the 
long-term outcome (Pollack et al., 1979; Riikonen, 1982). Psychiatric disorders are 
diagnosed in approximately 28% of children (Riikonen, 1984), with autistic spectrum 
disorder and attention deficit hyperactivity disorder being equally represented. Other seizure 
types and syndromes follow infantile spasms in 50 to 60% of children. These include 
complex partial seizures and the Lennox-Gastaut syndrome, which are the most common 
forms (Riikonen et al., 1981; Riikonen, 1982). Unfavorable prognostic factors include a 
symptomatic aetiology, onset earlier than 3 months (Jeavons et al., 1973a) and the presence 
of other types of seizures before the spasms. A better prognosis is associated with the 
absence of these factors and also mild or absent mental deterioration at the onset of therapy 
(Jeavons et al., 1973a).
1.1.2.4. Treatment
Infantile spasms are difficult to treat and usually resistant to conventional antiepileptic 
drugs. Corticosteroids, ACTH, vigabatrin (VGB), sodium valproate, benzodiazepines and 
pyridoxine have been found to be effective in seizure control in a proportion of cases, but 
even after successful treatment children are commonly left with severe developmental
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delay. The mode of action of these drugs remains unknown. Most studies are retrospective 
and there is a paucity of prospective studies and even fewer randomised or controlled 
treatment trials. The American Academy of Neurology and the Child Neurology Society, 
reviewing the medical treatment for infantile spasms, concluded that ACTH is probably 
effective for the short-term treatment of infantile spasms and resolution of hypsarrhythmia, 
but there is insufficient evidence to determine its optimum dosage and duration of treatment 
(Mackay et al., 2004). A meta-analysis of the literature concerning treatment of infantile 
spasms concluded that the optimum treatment remains uncertain (Hancock et al, 2003). 
Only ten randomised controlled trials (RCTS) were found at that time. Of these studies none 
showed any drug to be more efficacious than any other in terms of long-term psychomotor 
development or subsequent epilepsy rates. Recommended first line treatments for infantile 
spasms also differ from country to country. In the United States ACTH (Bobele et al., 1994) 
is the first-line agent, while in Japan pyridoxine followed by valproate and ACTH (Ito et 
al., 2000) are the first-line agents. In the 1990s, Vigabatrin (VGB) was introduced in 
Europe as an effective treatment for infantile spasms, particularly in tuberous sclerosis 
(Aicardi et al., 1996). The United Kingdom Infantile Spasms Study (UKISS) results 
comparing VGB (150mg/kg per day) with prednisolone (40 mg per day) or intramuscular 
tetracosactide (0.5mg) on alternate days in a multicentre, randomised controlled trial have 
shown that hypsarrhythmia resolved in more infants on hormonal treatments (81%) than on 
Vigabatrin (56%). The primary outcome was cessation of spasms on days 13 and 14. 
Cessation of spasms was more likely in infants given hormonal treatments (73%) than those 
given VGB (54%). There was no difference in outcome between the two hormonal 
treatments. 21 (70%) infants responded to prednisolone and 19 (76%) to tetracosactide (Lux 
et al., 2004). Response to treatment was also not affected by the underlying aetiology. 
Infants with tuberous sclerosis were not included in the UKISS study, given their 
assessment of the existing data of a good response to VGB in infants with IS and TS. In a 
follow up study absence of spasms at 14 months of age was similar in each treatment group. 
The neurodevelopment score using the Vineland adaptive behaviour scales (VABS) on an
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intention treat basis did not differ significantly between hormone or vigabatrin treatment. In 
infants with IS and no identified underlying aetiology the mean VABS score was higher in 
infants being treated with hormones than in those allocated VGB (Lux et al., 2005). Only 
one small study evaluated the cognitive long-term effect outcome in children with IS and 
TS treated with VGB in which the cessation of spasms with VGB was associated with a 
significant improvement in cognition and behaviour, including recovery from autistic 
behaviour (Jambaque et al., 2000). Although Vigabatrin is generally well tolerated, there is 
evidence of irreversible concentric visual field defects in 30-50% of patients of all ages 
treated with VGB (Gross-Tsur et al., 2000; Vanhatalo et al., 2002). Although this side 
effect of VGB is worrying, in the context of intractable seizures or the encephalopathy of 
infantile spasms, the therapeutic benefits must be weighed against the risks.
The effect of short tern treatment on long-term outcome was outside the purpose of this 
study. The medical treatment of IS was rigorously assessed in a review by Mackay et al 
2002 using class I, II and III evidence according to the American Academy of Neurology. 
The object of their review was to subject established empirical medical treatment regimens 
for infantile spasms to evidence-based medicine analysis in order to determine the current 
best practice for the treatment of infantile spasms in children. There was no strong evidence 
that successful treatment of infantile spasms improves the long-term prognosis for cognitive 
outcome or decreases the incidence of later epilepsy.
1.1.2.5. Current knowledge about causes for cognitive outcome in infantile spasms 
The cause of the bad cognitive outcome in infantile spasms is unknown. A current concept 
is that the interictal EEG activity may be the primary cause for cognitive impairment as 
hypothesised for the Landau-Kleffner syndrome and CSWS (Dulac, 2001; Holmes, 2002). 
Whilst the mechanisms for the poor neurodevelopmental outcome in children with IS are 
unknown, there is growing evidence that the mechanism for the poor outcome may be
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related to functionally abnormal temporal lobes during a critical phase of development 
(Bolton et al., 1997; Asano et al., 2001; Bolton et al., 2002).
1.1.2.5.1. Evidence for functionally abnormal temporal lobes
Social cognition includes information processing about all people, including the self
and about the norms and the procedures of the social world (Beer and Ochsner 2006).
A unique human component of social cognition, which is the ability to explain and predict 
other people’s behaviour by attributing to them different independent mental states, such as 
beliefs and desires, is known as having a “theory of mind (ToM)”.
Through lesions studies in primates, imaging studies, including fMRI, PET and MEG 
experiments social cognition has been associated with essential brain regions of the 
temporal and frontal lobes.
The temporal lobe involves regions including the extrastriate body area of the posterior 
temporal cortex (association with perceiving the form of other bodies (Saxe et al 2004), 
posterior superior temporal sulcus (association with interpreting the motions of a human 
body in terms of goals, Saxe et al., 2004, Ramnani et al., 2004), the temporoparietal 
junction supporting the human ability to reason about the contents of mental states (Saxe et 
al., 2003) and the temporal poles ( critical for aspects of face processing, specifically 
recognition from auditory and visual clues). Subregions of the medial prefrontal cortex are 
also implicated in the processing of social cognition. While the ventral medial prefrontal 
cortex appears to support emotional empathy (Blair 2005), the dorsal medial cortex is 
implicated in representing shared or collaborative attention and goals; being triadic_relations 
between me, you and this (Tomasello et al., 2005).
There is evidence that children with autism have a lack of social cognition and ToM (Hill 
EL et al., 2003), which may explain the failures of communication and social interaction.
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While temporal regions implicated in social perception, language and theory of mind 
abilities may be impaired in autism, the temporal lobe may also be functional abnormaljn 
epileptic EEs. The evidence comes from the Landau-Kleffner (LKS) syndrome, which is the 
classical example of subclinical seizure activity and centro-temporal epileptic discharges in 
sleep associated with cognitive and language impairment (Section 1.1.1.3.1).
Temporal lobe focal abnormalities were seen in seventy-three out of two hundred and 
fourteen children with infantile spasms in a long-term follow-up study. The temporal lobe 
was significantly more affected in children with autistic or hyperkinetic behaviour and in 
children with neonatal hypoglycaemia (Riikonen, 1982).
In addition the late appearances of a temporal lobe focus in many children following IS 
have been confirmed by systematic EEG studies (Riikonen, 1982). Temporal lobe focal 
abnormalities were seen in seventy-three out of two hundred and fourteen children with 
infantile spasms in a long-term follow-up study. The temporal lobe was significantly more 
affected in children with autistic or hyperkinetic behaviour and in children with neonatal 
hypoglycaemia (Riikonen, 1982). Patients with structural lesions and evidence of epileptic 
discharges in the temporal lobe may also have a poor neurodevelopmental outcome and 
autistic spectrum disorder (Raymond et al., 1994; Neville et al., 1997; Gomez et al., 1999; 
Taylor et al., 1999). Structural evidence for temporal lobe involvement arises from the 
finding that tubers and developmental tumours within the temporal lobe, are strong 
predictors of an autistic spectrum disorder (Raymond et al., 1994; Taylor et al., 1999). The 
association between tuberous sclerosis and autism or atypical autism has also been related 
to the presence of tubers in the temporal lobes, the risk of mental retardation increased with 
an increasing number of tubers (Bolton et al., 1997). Patients with tuberous sclerosis are at 
high risk of developing an autism spectrum disorder when temporal lobe tubers are 
associated with temporal lobe epileptiform discharges and early-onset, persistent spasms­
like seizures (Bolton et al., 2002). This risk was less if seizures started in the second year of
39
life. There is also an association between cognitive and behavioural impairments in children 
with dysembryoplastic neuroepithelial tumours (DNT) presenting with epilepsy, especially 
when the lesions involved the temporal lobe. Of the children with DNT, the most severely 
regressed, with prominent autistic features, frequently had right temporal lesions and the 
onset of epilepsy in the first year of life (Neville et al, 1997; Taylor et al., 1999). There is 
further evidence from Fluoro-D-Glucose positron emission tomography (PET) and 
electrophysiological studies, that children with autistic spectrum disorder associated with IS 
have dysfunctional temporal lobes. Children with tuberous sclerosis and a history of 
infantile spasms are more likely to have a communication disorder if they have glucose 
hypometabolism in the lateral temporal gyri (Asano et al, 2001). In a study of 17 infants 
with cryptogenic infantile spasms, cortical hypometabolism was detected in 11 infants on 
the first PET and in five infants on the second PET. The rate of developmental delay at the 
last follow-up was significantly higher in infants with hypometabolism than in those 
without PET abnormalities. In these children the temporal region was always involved in 
the area of focal hypometabolism (Itomi et al., 2002). Chugani and colleagues also 
documented hypometabolism most commonly in the parieto-occipito-temporal region and 
the outcome was especially poor in infants having bilateral temporal hypometabolism 
(Chugani et al, 1996). There is also electrophysiological evidence of a deficit in auditory 
information processing and automatic memory in children with TS having the autistic 
spectrum disorder compared to children with TS (Seri et al., 1999).
Therefore we hypothesize that the temporal lobe is functionally abnormal in children with 
infantile spasms and that this occurs early in the course of the syndrome. The auditory 
processing system is part of temporal lobe function and can be investigated with auditory 
event related potentials (ERPs), which may be recorded in infants independently of arousal 
and attention. We used therefore auditory ERPs to assess the temporal lobe function in 
infants with infantile spasms.
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1.2. The central auditory system and event related potentials
1.2.1 The anatomy of the temporal lobe and the neuroanatomy of the central auditory 
system
The lateral region supports auditory function (primary, secondary and association auditory 
cortex), speech and the integration of information arriving from sensory association areas. 
The integrated information is distributed to other brain regions for emotional (ventromedial 
lobe), cognitive (frontal association area) or motor (basal ganglia) processing for 
elaboration or response preparation. The ventromedial region of the temporal lobe contains 
the limbic system with the parahippocampal gyrus, the entorhinal cortex, the hippocampal 
formation, the uncus, the amygdale and the cortex of the temporal pole (Martin 1996).
Once an auditory impulse has been generated in the cochlea the signal travels along the 
auditory nerve to the cochlear nuclei. From there projections lead to the contralateral 
inferior colliculus via the lateral lemniscus while other projections undergo an additional 
stage of processing at the superior olivary nuclei. The superior olivary nuclei are involved 
in sound localization and binaural processing. The axons of the olivary neurones do also 
project to the homolateral inferior colliculus via the lateral lemniscus. The neurons of the 
inferior colliculi project via the brachium of the inferior colliculus to the medial geniculate 
body, which then projects via the auditory radiation to the primary auditory cortex 
contained in the transverse temporal gyri of Heschl (Musiek et al., 1986; Musiek, 1986a; 
Musiek, 1986b).
Our knowledge of the anatomical and functional organization of the human auditory 
cortical system comes largely from studies in non-human primates using microelectrode 
recordings, tracer studies and histochemical analyses. The anatomical and neurophsiological 
findings in monkeys support the idea of multiple, parallel streams of processing in the 
primate auditory system involving temporal, parietal and frontal cortices. Functional
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neuroimaging evidence indicates that a similar organisation might underlie human auditory 
system (Scott et al., 2003).
The auditory information is relayed from the ventral nucleus of the medial geniculate 
complex (MGv) to three primary areas of auditory cortex (“core”) (Figure 1.1), which 
project callosally to the auditory core of the other cerebral hemisphere and also to the 
surrounding “belt” (Figure 1.2) composed of several different cortical areas. These “belt” 
areas are connected to “parabelt” areas (Figure 1.3). These areas are distinguished from 
each other by having different systematic representations of the cochlea (cochleotopic 
organization) and their responses to different pure tones/frequencies (tonotopic 
organization, Figure 1.1). There is evidence of at least three levels of auditory processing in 
a hierarchical manner from MGv—> core—» belt—> parabelt (Figures 1.2 and 1.3). The 
parabelt is interconnected with adjacent portions of the temporal cortex (superior temporal 
gyrus and sulcus), parietal lobe and several regions of the frontal lobe. These further 
connections can be considered components of an additional, fourth level of auditory 
processing (Figure 1.3; Kaas et al., 1999; Kaas et al., 2000). Studies of human auditory 
cortex show a similar anatomical organization mapping auditory core, lateral belt and 
parabelt cortices in the superior temporal gyrus (Sweet et al., 2005).
The auditory system shows specialized pathways for processing of acoustic signals present 
within the environment (“what”) and to localize the direction from which these signals 
originate (“where”). A “what” stream involves rostral belt and parabelt, which are 
connected with the anterior superior temporal gyrus and sulcus and multiple sites within the 
ventrolateral and dorsolateral frontal cortex (Figures 1.4 and 1.5). A “where” stream for 
sound localisation involves the caudal auditory belt and parabelt, which are connected with 
the posterior superior temporal gyrus and sulcus, parietal cortex, ventrolateral and 
dorsolateral cortex (Figures 1.4 and 1.5).
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Figure 1.1. Tonotopic organization in the auditory core of the monkey. Auditory core fields 
(Al, R, RT) are surrounded by belt fields (not labeled).
Curved lines within each field depict isofrequency contours. High- (H) frequency acoustic 
stimuli are represented caudomedially in Al, rostromedially in R. Low- (L) frequency 
stimuli are represented rostrolaterally in Al, caudolaterally in R. Tonotopic organization in 
RT is not as certain but may mirror that found in R (Kaas et al., 2000).
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Figure 1.2. Auditory cortical connections of the primary auditory cortex (Al) in the 
monkey.
Area Al, as well as other core areas, has dense reciprocal connections with adjacent areas of 
the core and belt (solid lines with arrows). Connections with nonadjacent fields are less 
dense (dashed lines with arrows). The core has few, if any, connections with the parabelt or 
more distant cortex (Kaas et al, 2000).
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Figure 1.3. Auditory cortical connections of the caudal parabelt (CPB) in the auditory 
cortex of the monkey.
Parabelt area CPB, as well as RPB, has dense connections with adjacent areas of the belt 
and RM in the medial belt (solid lines with arrows). Connections with nonadjacent fields of 
the belt tend to be less dense (dashed lines with arrows). The parabelt fields have few, if 
any, connections with the core areas. The parabelt also has connections with the 
polysensory areas in the superior temporal sulcus (STS) and with functionally distinct fields 
in prefrontal cortex (Kaas et al, 2000).
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Figure 1.4. Specialization in the primate temporal lobe. Inset shows the supra-temporal 
plane in greater detail.
Abbreviations for figure 1 to 4: Al, auditory area I; R, rostral area; RT; rostrotemporal area; 
CL, caudolateral area; CM, caudomedial area; ML, middle lateral area; RM, rostromedial 
area; AL, anterolateral area; RTL, lateral rostrotemporal area; RTM, medial rostrotemporal 
area; CPB, caudal parabelt; RPB, rostral parabelt (Scott et al., 2003).
46
W here
T2/T3
Core
Cortex Thalamus
Figure 1.5. Schematic flow diagram of "what" and "where" streams in the auditory cortical 
system of primates.
The ventral "what"-stream is shown in green, the dorsal "where"-stream, in red. Al primary 
auditory cortex; R, rostral area; CM, caudomedial area; AL, anterolateral area; ML, middle 
lateral; CL, caudolateral; PP posterior parietal cortex; PB, parabelt cortex; MGd and MGv, 
dorsal and ventral parts of the MGN (medial geniculate nucleus), T2/T3 (anterior pole of 
the temporal lobe).
(Rauschecker et al., 2000).
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1.2.2. Electrophysiological indices o f the auditory system function 
Electrophysiological responses to sound can be measured non-invasively, objectively and 
precisely by using auditory evoked potentials (AEPs). These are the electrical responses of 
the nervous system to sound, recorded on the surface of the scalp. The mechanisms 
involved in the genesis of event-related potentials are still not yet fully understood. It is not 
known whether ERPs arise due to the contribution of a fixed-polarity and fixed latency 
superimposed neuronal activity to background electroencephalograhic oscillations (evoked 
model, Schroeder et al., 1995, Maekinen et al., 2004) and/or due to a partial phase 
synchronization of the ongoing EEG (oscillatory model, Makeig et al., 2002, Kruglikov and 
Schiff, 2003). Recent theoretical studies have proposed that ERP characteristics (phase 
resetting and power enhancement) could be a consequence of the level of activity of the 
neuronal networks involved in their generation (David et al., 2005).
Scalp-recorded cortical AEPs are principally a reflection of post-synaptic dendritic 
potentials (Luck, 2005). The interface through which they interact with surrounding neurons 
usually consists of several dendrites (input connections), which are connected via synapses 
to other neurons, and one axon (output connection). If the sum of the input signals surpasses 
a certain threshold, the neuron sends an action potential (AP) at the axon hillock and 
transmits this electrical signal along the axon. Neurons of a particular functional area such 
as the primary auditory cortex will tend to fire together if the stimulus is sufficient. These 
neurons are extensively connected both to each other and other neuronal groups. The 
neurons which will fire depend on the characteristics of the input and of its processing. This 
notion of interconnected groups of neurons selectively involved in specific functions is 
called a neuronal network
If an excitatory neurotransmitter is released at the apical dendrites of a cortical pyramidal
cell, current will flow from the extracellular space into the cell around the apical dentrites,
and currents flow out of the cell body and basal dentritites at more distal sites, creating a
dipolar source -sink configuration oriented perpendicular to the cortical sheet. The opposite
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happens if the distal parts of the dendrites are activated. As hundreds of thousands of such 
cells are activated, a summated potential may be detected on the surface of the scalp (Kuta 
et al., 1997). The (usually scalp-recorded) average of all the cellular sources and sinks can 
be summarised as an “equivalent dipole”. The summated potential on the scalp is only 
observable on the scalp if the average distribution of positive (“sources”) and negative 
(“sinks”) potentials in the neurons are distributed in a non-radially symmetric fashion and 
the neurons are aligned systematically and are activated synchronously (Figures 1.6 and 1.7; 
Kuta et al, 1997). The neocortex of the brain fulfils these criteria above. Around 70% of 
the cells in the neocortex are pyramidal cells having apical dendrites extending from their 
soma towards the surface of the sheet, giving the cortex a columnar appearance.
Human AEPs are generally divided into auditory brain stem responses (ABR), middle- 
latency responses (MLR) and long-latency responses (Figure 1.8). Auditory brain stem 
responses seen within the first 10ms after the stimulus are widely used clinically to assess 
auditory sensitivity and to detect abnormalities of peripheral and brainstem portions of the 
auditory pathways (Biacabe et al., 2001). Middle latency potentials (MLR) occur 10-80ms 
after an acoustic stimulus and are also characterised by several components (Liegeois- 
Chauvel et al., 1994). MLR may be detected in children during wakefulness and sleep 
stages 1, 2 and REM, but less during stage 4 (Kraus et al., 1989, Kraus et al., 1995). Longer 
latency potentials (>80ms) are thought to reflect higher auditory cortical processing as 
discussed below.
1.2.3. Time and phase-locked auditory potentials
Auditory evoked potentials are small and therefore are usually masked by the background
activity (noise) of the EEG and individual responses cannot be distinguished. The technique
of signal averaging serves to extract the responses, which are time-locked to the stimulus,
from unrelated potential changes. Ideally the repeated presentation of an identical stimulus
will evoke to the same potential (signal) waveform. By collecting and adding each response
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to the preceding one, the underlying evoked potential will remain unchanged and the 
random noise will tend to average out (towards zero). A computer with an analog-to-digital 
converter carries out averaging, records the continuous voltage changes during selected 
time intervals (epochs), adds the responses of multiple epochs and divides them finally by 
the number of trials to arrive at a mean for each epoch and displays the waveform on the 
screen. The relationship between the signal to noise ratio (SNR) and the number of 
responses is not linear: the SNR improves by the square root of the number of responses 
that are averaged (Luck, 2005). It may be therefore difficult to average the signal out of the 
very abnormal background EEG noise as seen in infants with IS, which will be considered 
further below.
1.2.3.1. Event-related potentials
The long-latency potentials are also called event related potentials (ERP), which can be
divided into exogenous and endogenous potentials in any one modality (Donchin et al.,
1978). Exogenous, or obligatory, ERP components are elicited by the occurrence of a
stimulus in the particular modality under consideration. They are determined by the
physical stimulus characteristics and change their properties only in relation to stimulus
features. In contrast, endogenous components do not obligatorily depend on the external
stimuli (Naatanen, 1992). They show a greater variability in comparison to the exogenous
components. They are thought to reflect mainly internally generated mental events related
to the cognitive assessment of the stimulus. According to Donchin et al (1978) endogenous
components must be non obligatory responses to stimuli. “Amplitude, latency and scalp
distribution of the endogenous potential are often invariant to changes in the physical
parameters of the eliciting stimulus. Quite disparate stimuli, even stimuli in different
modalities elicit the same components if their task-roles are equivalent. The variance of
endogenous components is normally accounted for by variation in the tasks assigned to the
subject”. The exogenous-endogenous distinction is nevertheless an oversimplification of the
real state of affairs. Almost all sensory early components have been shown to be modifiable
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by attention and the later cognitive components have been shown to be influenced by the 
modality of the stimulus. Thus those ERP components occurring within the first 100-200 
ms tend to be more exogenous, while those occurring later tend to be more endogenous 
(Rugger al., 1996).
1.2.3.1.1. Exogenous (obligatory) auditory ERPs
1.2.3.1.1.1. Obligatory auditory ERPs in adults and school-age children
The first obligatory component of long latency auditory ERPs in adults is a positive 
deflection PI, sometimes also called P50, peaking around 50 ms. When recording evoked 
potentials from the auditory cortex in man the generator of the P 50 was found to lie in the 
lateral portion of the Heschl’s gyrus (HG), i.e. the primary auditory cortex (Liegeois- 
Chauvel et al., 1994). The second component, the first negative component, is the N1 
response peaking around 100 ms. This peak is composed of multiple, partly temporally 
overlapping, independent components observed at the vertex and over lateral temporal 
electrode sites (Naatanen et al., 1987). The first component, the vertex N1 has a fronto- 
central negativity with a peak latency of 100ms and is generated by bilateral vertically 
oriented dipoles on the supratemporal planes of the auditory cortices (Vaughan et al., 1970) 
including secondary auditory cortex lateral to the HG. The second component of the N1, 
first described by Wolpaw and Penry (1975) who called it the ‘T  complex”, is biphasic and 
has a positive peak at around 80 ms and a negative one at around 130 ms. This complex 
originates in the auditory association cortices in the superior temporal gyri (secondary 
auditory cortices) and can be modelled by bilateral radially oriented dipoles (Picton et al., 
1999). The third component is a vertex-negative wave with a latency of 100 ms, generated 
in modality non-specific areas (Naatanen et al., 1987). The components N la and Nlc refer 
to the positive and negative components of the T-complex respectively and Nib refers to 
the vertex N1 (Giard et al., 1994).
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The N1 component is followed by a second positive polarity, P2, with a latency of 
approximately 150-250 ms. The topography of the P2 appears to be similar across auditory, 
visual and somatosensory modalities, being maximal over the vertex (Oades et al., 1995; 
Potts et al., 1998). Using magnetoencephalography (MEG) and EEG data P2 generators 
were localized in the planum temporale as well as area 22 (the auditory association 
complex), (Godey et al., 2001).The localisation of P2 in area 22 was only found using the 
MEG data, but this finding is consistent with the MEG data by Hari et al (1987), locating 
the generator anterior to the generators of the N1 peak. Further studies indicate that the P2 
reflects at least partly auditorly driven output of the mesencephalic reticular activating 
system, which responds to input from all sensory modalities (Knight et al, 1980; Naatanen 
et al., 1987; Rif et al., 1991, Woods et al., 1993; Crowley et al, 2004).
The P2 is followed by a pronounced second negativity, N2, which has an adult latency of 
220-270ms (Ponton et al, 2000). It has been suggested that the N2 has bilateral generators 
in the supratemporal auditory cortex (Gomot et al., 2000; Ceponiene et al., 2002b). The N2 
generation in 5-11-year-old children might also have additional frontal and parietal cortical 
fields involved (Gomot et al., 2000). The N2 is a component, which has mainly been 
reported in children, but it has also been recorded in adults, but with a smaller amplitude 
(Ponton et al., 2000) and in some reports longer latency (Ponton et al., 2000). The N2 
amplitude in children is largely insensitive to stimulus rate, but changes as a function of the 
stimulus content (Ceponiene et al., 1998).The N2 was larger in response to complex rather 
than simple tones and to low pitched rather than high-pitched tones.
1.2.3.1.1.2. Maturation of obligatory auditory ERPs during infancy 
In previous studies of infant ERPs a predominant positive deflection at about 300 ms has 
most commonly been labelled as P2 and a later negative deflection at about 500-600ms as 
N2, but the labelling between laboratories varied and the infantile peaks did not correspond 
to the adult peaks with the same labels. Differences in nomenclature, recording montages,
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stimuli, interstimulus-intervals and waking state makes a comparison between these studies 
very difficult (Table 1.1). Most of these studies showed increasing peak amplitudes with 
age and shortening of latencies. Peak amplitudes did not increase linearly. Vaughan et al 
(1992) showed an inverted-U function at 6 months, but this was not shown by other studies 
(Ohlrich et al, 1972; Shucard et al., 1987a; Shucard et al, 1988). Latencies of ERP peaks 
generally decreased with development; however Shucard et al (1987) found an increasing 
latency within the first 3 months. Cortical auditory ERPs recorded longitudinally from birth 
until 12 month of age at 3-monthly intervals, showed 4 components labelled as P I50, N250, 
P350 and N450 (Kushnerenko et al, 2002a). 5 awake infants were recorded monthly 
between 3 and 24 months of age by (Jing et al, 2006). The latencies of the PI50, N250, 
P350 and N450 components gradually decreased with increasing age. The amplitudes of the 
N250 and P350 components gradually increased and reached a maximum at 9 months of 
age and then gradually decreased with increasing age.
1.2.3.1.2. Endogenous discriminative components of the auditory ERP 
The endogenous components can be elicited in the oddball paradigm where infrequent 
stimuli (“deviants”) are embedded in a series of repetitive identical (“standard “) stimuli. 
These deviant stimuli differ from the standards in one or more characteristics. Oddball 
paradigms may be used during recordings in which the subject is either actively paying 
attention or not. During the active recording the subject’s task is to react with a motor 
response or just by silently counting a particular class of target (deviant) stimuli embedded 
into a sequence of otherwise irrelevant non-target stimuli. If not actively paying attention, 
the subject is asked to ignore all the stimuli and sometimes asking the subject to read a book 
or to watch a silent video reinforces this. Because infants and young children are unable to 
follow an instruction to actively attend to the stimulus, ERP paradigms in this age group are 
regarded as passive. The endogenous components occurring after 100-200ms from stimulus 
onset require no mental activity on part of the participant for their evocation. Among the
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endogenous components elicited in the oddball paradigm and described further on are the 
MMN, the P3a and the late negativity (Nc), which are passively elicited.
1.2.3.1.2.1. The Mismatch-Negativity
The mismatch-negativity (MMN) has an adult latency between 100 and 250ms from change 
onset. Presenting the subject with a block of several hundred identical stimuli (“standards”), 
which are occasionally replaced by acoustically deviant stimuli, and thereafter subtracting 
the response elicited by standards from that elicited by the deviants elicits the MMN 
(Naatanen et al., 1995). This neural mismatch process between a deviant sensory input and 
the neural representation or sensory memory trace formed by the repetitive standard sounds 
appears to be automatic since the MMN is elicited even by changes in unattended auditory 
stimuli. In adults the largest amplitudes of the MMN are recorded over the fronto-central 
scalp. MEG studies and intracranial recordings have found major generators bilaterally in 
the auditory cortices. Although the MMN may be demonstrated reliably during adulthood 
(Naatanen et al., 1995), it is not found consistently during infancy (Morr et al., 2002). There 
is a great intersubject variability of the MMN in latency and amplitude of the MMN in the 
same infants from birth to 1 year of age at a 3-month follow-up study. A MMN present at 
birth may be absent at 3 months of age in the same normal developing infant. There was 
also no significant decrease of the MMN latency with age during the first year of life 
(Kushnerenko et al. 2002b). Finding the MMN in normal developing infants may be 
difficult, but demonstrating it in infants with a very abnormal EEG and an anticipated very 
low signal to noise ratio may be impossible. This was also part of the investigation reported 
in this thesis.
1.2.3.1.2.2. The P3a
Novelty detection is a fundamental capacity of all mammalian nervous systems (Sokolov, 
1963). The ability to orient to novel, unexpected or unpredictable events is critical for both 
survival (Sokolov, 1963) and normal memory function (Von Restorff, 1933). The use of a
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novelty oddball paradigm (low-probability novel stimuli in addition to target and standard 
stimuli) demonstrated that involuntary orientation to an unexpected and novel stimulus 
generated a P300 response, recorded between 250-350ms post stimulus onset (Courchesne 
et al, 1975; Squires et al, 1975). This Novelty P300, also referred to as P3a response, may 
be elicited both by attended and unattended stimuli and habituates across successive 
presentations of novel items. Although some P300 responses have been elicited by simple 
stimuli and labelled as novelty responses the P3a is most clearly elicited by stimuli which 
are unexpected in the context set by the standard stimulus (Squires et al., 1975; Simons et 
al., 2001). It has to be distinguished from the P3b response, which is generated by voluntary 
detection of a task-relevant event, by a shorter peak latency, smaller amplitude and a 
different (fronto-central vs centro-parietal) scalp topography (Sutton et al., 1965). Both the 
P3a and P3b have been observed in all sensory modalities (Knight, 1984; Knight, 1996).
The preffontal cortex and the medial temporal lobes are important components of the 
network generating the novelty P3.
Intracranial recordings of patients with epilepsy have shown that novel stimuli activate a 
distributed network including the bilateral dorsolateral, ventrolateral, and orbital prefrontal 
cortex, cingulate cortex, lateral temporoparietal cortex, hippocampus and parahippocampal 
cortical regions (Figure 1.9, Halgren et al., 1995a; Halgren et al., 1995b; Baudena et al., 
1995). Patients with focal brain lesions involving either lateral prefrontal, lateral 
temporoparietal or posterior medial temporal regions have also shown attenuated novelty P3 
responses in all modalities (Figure 1.10, Ranganath et al 2003).
The ability to detect and respond to novel stimuli in the environment is especially important 
in infants and young children as they have to process many novel events. Developmental 
studies showed a decreasing latency of the novelty P3 and a more frontal topography 
between the ages of 5-16 years (Cycowicz et al., 1996; Cycowicz et al., 1997). In adults and 
children (7-13 years) an early- (eP3a; peak latency 200-250ms) and a late component (IP3a; 
peak latency 250-350 ms) of the P3a have also been identified (Escera et al., 1998; 
Gumenyuk et al, 2001). In adulthood characteristics of the early component are maximal
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amplitude over the fronto-central scalp and polarity inversion over the lateral and posterior 
scalp sites. By contrast, the IP3a is maximal frontally, distributed more anteriorly to the 
eP3a and does not show an inverting polarity over the posterior scalp (Escera et al., 1998). 
There is currently no systematic study of auditory novelty ERP during infancy. 
(Kushnerenko et al, 2002b) reported pilot data on novelty ERP in six newborns and six 2 
year olds, without specifying the state of arousal during recording. Newborns, which were 
presented with an auditory oddball paradigm including novel environmental sounds, 
showed a different distribution and ERP waveform in response to novel than to the deviant 
stimuli during quiet sleep. This may suggest that the auditory detection mechanism for 
novelty is already present in the newborn period (Sambeth et al., 2006).
1.2.3.1.2.3. Late negativities in attended conditions
The late negativity component (Nc) with a peak latency of about 300-1000 msec and fronto- 
central distribution scalp distribution may be regarded as a sign of enhanced auditory and 
visual selective attention, since it was elicited in response to surprising, interesting stimuli. 
The amplitude of the Nc is maximal during childhood, and decreases during adulthood 
(Courchesne, 1990). Recording auditory stimuli in 9-13 years old children and using left 
and right mastoid electrodes as a reference two components of the Nc following each other 
may be differentiated. The first component (Ncl) had a peak latency of 400-750ms and was 
followed by a second component (Nc2) at a latency of 800-1100ms (Ceponiene et al,
2004). It is therefore reasonable to suggest that the frontal predominance of the early 
portion of Nc has at least some of its generator sources residing in the frontal lobe 
(Ceponiene et al., 2004).
1.2.4. Influence of sleep on auditory ERP recordings
In the newborn period, physiological measures other than EEG parameters such as EMG
tone, phasic twitches, rapid eye movements and respiratory regularity are the most useful
features to differentiate between wakefulness, non-rapid eye movement (NREM) sleep and
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rapid eye movement (REM) sleep (Anders, 1971). In the first few months of life NREM is 
classified as quiet sleep and REM as active sleep. Quiet sleep is conventionally 
differentiated into four sleep stages. Stage 1 is characterised by bursts of high-voltage, 
rhythmic theta activity, sleep stage 2 by sleep spindles and K complexes and stages 3 and 4 
contain slow, high-voltage delta waves (also called slow-wave sleep or delta sleep). Stages 
2, 3 and 4 EEG patterns occur only in NREM sleep state, whereas the stage 1 EEG pattern 
can occur in wakefulness, REM sleep and NREM sleep (Anders, 1971). During sleep, REM 
and NREM states alternate and follow each other in a periodic fashion and compose 
together a sleep cycle (Anders, 1971). This alternating REM/NREM organization is seen by 
4 months of life (Kahn et al., 1996).While the amount of quiet sleep increases with age, 
active sleep decreases. Quiet sleep is the dominant sleep phase in 60% of infants at 3 
months and in 90% of 6-month-old-infants, when the proportion of quiet sleep is twice that 
of active sleep (Kahn et al., 1996).
Auditory ERPs of newborns do not appear to differ significantly from each other when 
obtained during active sleep or wakefulness (Ellingson et al., 1974; Kurtzberg et al., 1984). 
Although there has been no systematic study in infancy or childhood reproducing this 
finding, this result has been used by several authors as justification for not distinguishing 
between findings in active sleep and wakefulness in their analysis. ERP studies in adults 
indicate that auditory information processing is selectively affected across the different 
stages of sleep (Atienza et al., 2001). The processing of external auditory stimuli is 
markedly reduced during stages 3 and 4 and rapid eye movement sleep (REM) (Ogilvie et 
al., 1988). There is currently no systematic evidence suggesting how auditory processing in 
infancy is affected by wakefulness and sleep. Stage 2 seems to be ideal to study having been 
identified as the most reliably and easily recognizable EEG pattern on having entered 
definite sleep (De Gennaro et al., 2001). This issue is also addressed in the current study.
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1.3. Aims of the present studies
Based on the aforementioned evidence (Section 1.1.2.4.1) that the temporal lobes are 
important in normal cognitive development and the evidence of temporal lobe involvement 
in the encephalopathy of IS, the hypothesis of this study is that the temporal lobes are 
functionally abnormal in infants with infantile spasms. Auditory long latency ERPs are 
thought to reflect higher auditory cortical processing and were therefore used in this study 
to support or refute this hypothesis. In order to test this hypothesis a major part of this study 
was also to study the ERPs in normal developing babies.
1.3.1. Primary Aims
1.3.1.1. Are obligatory and novelty auditory ERP components measurable in infants with IS 
within the first 14 months of life in the context of a very abnormal EEG?
1.3.1.2. Are obligatory and novelty auditory ERP components measurable in normal 
developing infants within the first 14 months of life and do they show any latency/ amplitude 
changes with increasing age ?
1.3.1.3. Are obligatory and novelty auditory ERP components in IS abnormal compared to 
control infants ?
1.3.1.4. Have age of seizure onset, response to treatment (seizure control after 2 weeks), 
development before the onset of spasms either being normal or delayed, abnormal MR1 
(symptomatic)/normal MRI (cryptogenic) a predictive value on initial ERP ?
1.3.2. Secondary Aims
1.3.2.1. Are there differences in auditory ERP components between waking and sleep state 
in infants with IS compared to control infants?
1.3.2.2. Are the infantile ERP peaks analogous to any childhood or adulthood peaks?
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CHAPTER 2: METHODOLOGY
2.1. Ethical considerations
The Research Ethics Committee of Great Ormond Street Hospital for Children (GOSH) and 
the Institute of Child Health (UCL) approved this study. The parents gave informed consent 
after reading an information leaflet (Appendix 1 and 2).
2.2. Participants
2.2.1. Controls
Thirty two healthy, normally developing infants aged 1-15 months were recruited through 
nurses and doctors at Great Ormond Street Hospital, UCL-Institute of Child Health, the 
National Centre for Young People with Epilepsy and some university colleagues. Criteria 
for normality were age-appropriate development and the absence of familial congenital 
hearing impairment, chronic otitis media or other significant health problems as obtained by 
parental interview.
2.2.2. Infants with infantile spasms
Thirty-four infants with infantile spasms aged 1-15 months were recruited from newly 
referred patients, the tuberous sclerosis clinic and the epilepsy programme at GOSH. 
Consultant paediatricians working in District General Hospitals were informed about the 
study by letter and by personal contact. They were encouraged to refer any newly diagnosed 
patients. Several educational talks for middle grade training and consultant staff were given 
at district general hospitals by Professor Neville and myself to raise awareness of this study 
and of the importance of infantile spasms. Inclusion criteria were clinical infantile spasms
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and an abnormal EEG compatible with IS with or without hypsarrhythmia. Infants with 
other seizure types, but without infantile spasms, were excluded from this study.
2.2.2.1. Clinical and developmental assessment of infants with infantile spasms 
All infants with infantile spasms were seen within 1 week of referral. The patients were 
seen by the candidate and a consultant paediatric neurologist who decided about 
investigations and treatment. The data including age of onset, description of the first seizure 
and of IS, response to treatment within 2 weeks with standard medication, history of 
development prior to onset of IS, observed developmental delay during IS, 
electroencephalogram, metabolic investigations and any indications of a possible 
underlying diagnosis including tuberous sclerosis, cortical malformation or a syndrome 
were prospectively obtained and later extracted from the notes using a standardized form 
(Appendix 3). The examination of IS included a developmental screening appropriate for 
age including fine motor and vision, gross motor, hearing and speech and social behaviour 
and play (Flehmig, 1992). Infants were categorized as normal or abnormal. In addition to 
the candidate and consultant, Dr Tim Cox, consultant neuroradiologist, at Great Ormond 
Street Hospital independently reviewed the magnetic resonance imaging scans of all 
patients for possible underlying structural brain abnormalities to arrive at a consensus 
diagnosis.
2.3. Instrumentation
The equipment for the acquisition of ERPs consisted of 2 systems. Auditory stimuli 
(Section 2.4.3) were delivered through a sound card in a PC. These stimuli were amplified 
using a Cambridge AlMark2 audio amplifier and played at an intensity of 75 dB sound- 
pressure levels (SPL) via two speakers placed at a distance of 30 cm from each ear of the 
infant. The EEG montage had 19 channels (Section 2.4.1). EEG signals were recorded and 
digitised at 500 Hz using ‘SYNAMPS’ amplifiers and ‘Neuroscan version 4.2’ software
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(Neurosoft Inc, Hemdon VA) running on a second PC, which controlled the display and 
storage to a hard disk for subsequent off-line analysis.
2.4. EEG and recording procedure
2.4.1. EEG
The EEG was recorded with a band pass filter of 0.15-100 Hz. Silver/silver-chloride 
electrodes were attached using adhesive paste according to the international 10-20 system at 
Fz, F3, F4, F7, F8, Cz, C3, C4, T3, T4, Pz, P3, P4, T5, T6, and left and right mastoids (Ml, 
M2). All were referenced to CPz. The ground electrode was placed on Fpl. Input 
impedance was kept below 10 kOhm.
2.4.1.1. EEG in infants with infantile spasms
Dr Stewart Boyd, consultant in paediatric clinical neurophysiology, who was blinded to the 
underlying pathology in the individual patient, independently examined the degree of EEG 
abnormality.
The following EEG criteria were assessed using these definitions:
1. Moderate abnormality
Unequivocal excess of slow activity of similar amplitude to the on-going activity, present 
for less then 50 % of the recording, with definite evidence of age-appropriate activity.
2. Severe abnormality
Continuous excess of slow activity and /or absence of age-appropriate rhythmic activity 
and frequent epileptiform features.
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3. Hypsarrhvthmia
The EEG abnormalities consist of diffuse, high amplitude, a non-synchronous paroxysmal 
and slow wave theta and delta activity with loss of background features that is continuous 
when awake and fragmented in sleep. This hypsarrhythmic pattern may be symmetrical or 
asymmetrical because of additional foci, or unilateral.
4. Exacerbation of EEG abnormalities bv sleep
Since EEG abnormalities may be more disorganized and of higher amplitude in sleep this 
variable was analysed separately (Section 1.1.2.2.2)
5. Persistent focal changes
The EEG had no focal discharges, multifocal discharges or L or R hemisphere focal 
discharges.
6. Ictal recordings of Infantile spasms
There are no specific ictal patterns associated with infantile spasms (Section 1.1.2.2.2). If 
infantile spasms were documented during the recording, the changes were categorized as:
la. Isolated transient lasting around 0.5s, positive at the vertex
lb. This (la) could be followed by an electrodecremental period (an abrupt reduction in the 
amplitude of all activities lasting more than Is, with disappearance of theta and delta 
activities) of up to 4sec,which in turn might or might not contain runs of more rhythmic 
activity.
2. A burst of faster components (12-20 ms): lateralisation was noted if present.
3. Other changes including bursts of spike-wave complexes.
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2.4.1.2. Sleep staging
EEG criteria for awake/drowsiness were presence of muscle activity and/or hypnagogic 
hypersynchrony (high amplitude rhythmic theta activity of drowsiness in infants, (Hughes, 
1994). Stage 2 sleep state was defined by the presence of sleep spindles, variable degree of 
irregular high amplitude slow delta activity (Rechtschaffen et al., 1968). In infants with 
infantile spasms the absence of muscle activity and some organisation of epileptic activities 
into bursts was classified as stage II sleep, if sleep spindles were not also present (Section
1.1.2.2.2. Watanabe etal. 1993; Mori et al. 1994).
2.4.2. Recording Procedure
Infants were tested in a sound-attenuated room during periods of wakefulness and sleep. 
Feeding, and recordings around midday encouraged infants to sleep on their mother’s lap. 
During wakefulness infants were engaged by their mothers. The recording session lasted 
between one and two hours. Recordings of ERP during wakefulness took place before and 
during feeding, while sleep ERP recordings took place after feeding. EEG criteria were used 
to define the onset of sleep (Section 2.4.1.2).
2.4.3. Experimental stimulation/oddball paradigm
The oddball paradigm stimulation consisted of frequent standard stimuli (sinusoidal tones, 
1kHz, 200 ms long with 10 ms rise and fall time, probability of occurrence p=80%) and 
infrequent deviants (1.5 kHz, 200 ms long, p=10%), and infrequent novel sounds (p=10%). 
Brief environmental sounds (mechanical and animal noises, musical instrument sounds etc., 
maximum duration 200ms, peak intensity less than 75 dB SPL) served as novel stimuli. A 
pseudo-random sequence was used in all recordings (Appendix 4). Stimulus onset 
asynchrony (SOA) was 700 ms. A stimulus block contained 923 stimuli (including 747 
standards, 88 deviants and 88 novels) and, whenever possible, 2 blocks were recorded 
during both wakefulness and sleep respectively.
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2.5. Data processing
Continuous EEG data were referenced to a common average reference. EEGs were 
reviewed off-line for movement and other major artefacts. The recordings of controls and 
patients were categorized into sleep and wake states on the basis of the predominant (more 
than 60%) EEG pattern (Section 2.4.1.2). ERP epochs were then constructed with 200 ms 
pre- and 1800 ms post-stimulus periods and baseline correction was applied to the -200 ms 
to 0 ms interval. The data were artefact rejected using an automated procedure with a 
specific amplitude threshold and visually inspected to eliminate clipped signals (amplifier 
saturation). As in other studies, epochs exceeding +/- 150 pV in the awake state (Cheour et 
al., 1998; Cheour et al., 2002) and +/- 250 pV in stage II sleep were automatically rejected 
before the averaging process in the control infants. There is no literature on recording 
similar auditory ERPs in infants or children with epilepsy and EEGs with high amplitude 
on-going activities. Infants with IS have a background with variable high amplitude of EEG 
activities (Section 1.1.2.2.2, Table 3.13). It was therefore not possible to use the same 
amplitude criteria as in normal controls. The rejection criteria for each of the infants with IS 
were therefore set with reference to the abnormal background activity of the EEG and the 
calculated signal to noise ratio.
2.6. Signal to noise ratio (SNR) considerations
An adverse SNR was anticipated in infants with IS. The duration of the recording was 
limited by the infant’s tolerance, the family’s commitments, the need to replicate responses 
to each stimulus and the need to record in two states. An SNR of 2 was therefore selected as 
a practicable compromise provided the ERP component was identifiable in multiple 
neighbouring electrodes as well as being replicable in at least 2 separate consecutive 
recordings. In conjunction with the paediatric neurophysiologist Stewart Boyd the average 
amplitude of background activity (“noise”) of the EEG during both wakefulness and sleep, 
excluding large amplitude spikes and waves, was estimated as an average amplitude from 
baseline by visual inspection in each individual patient with IS. The estimated background
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activity in each patient with IS was compared with the peak to peak amplitude of the 
novelty or obligatory “signal” measured in normal infants. The SNR ratio improves with the 
square root of the numbers of epochs averaged (Section 1.2.3.). The necessary averages to 
obtain a SNR of 2 may therefore be calculated in wakefulness and sleep.
2.7. Measurement of ERP components
The peak latency of components was identified by visual inspection of the waveforms, and 
measured with an electronic cursor. The amplitude of components was measured from 
baseline to peak of sequential components. As noted above, the component had to be clearly 
visible across multiple neighbouring electrodes and replicable in at least two consecutive 
blocks in the same state of arousal.
2.7.1. Obligatory ERP
Obligatory ERPs to frequent standard tones were re-referenced to the mean of both mastoid 
electrodes Ml and M2 and low pass filtered at 10 Hz for comparison with previous reports 
(Kushnerenko et al, 2002a). Measurements were taken at a positive peak (P150) followed 
by a negative (N250) and a further positive peak (P350) at electrodes F3, Fz, F4, C3, Cz and 
C4 in wakefulness and sleep (Figure 2.1).
2.7.2. Mismatch-Negativity
All electrodes were re-referenced to the mean of both mastoid electrodes Ml and M2. The 
MMN waves were obtained by subtracting the response to the last standard stimulus from 
that before a deviant stimulus, high pass filtered at 1Hz and low pass filtered atlO Hz. The 
MMN was defined as the largest negative deflection in the difference waveform between 80 
and 300ms after stimulus onset, greater than the average baseline voltage by 1.0 pV at any 
two of the four-central electrodes (F3, F4, C3 and C4).
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2.7.3. Novelty ERP
Negative components over bilateral inferior temporal and mastoid electrodes (labelled 
N250) and positive components over the fronto-frontolateral-central region (labelled P250F, 
P250FL and P250C) were measured. The early P250 (eP250), the late P250 (1P250), early 
N250 (eN250) and late N250 (1N250) components were measured at F3, F4, C3, C4 and 
mastoid (Ml, M2) and inferior temporal (P7, P8) electrodes. Long-latency negative waves 
(labelled Ncl and Nc2) were measured over the fronto-central midline (F3, F4) and more 
prominently with longer latencies over dorso-lateral frontal regions (F7, F8). Positive slow 
components (P500) were measured in bilateral mastoid and inferior temporal leads (Figure 
2 .2).
Sleep specific central negative components (labelled NcS) were measured at central 
electrodes C3, C4 and Cz (Figure 2.3). To improve the detection of peak amplitudes and 
latencies for novelty ERPs, signals were low pass filtered with a 10 Hz zero-phase digital 
filter (slope 6 dB).
2.8. Analysis with reference to the primary and secondary aims
In order to analyse the IS data, the first step was to compare group mean averages of ERP 
waveforms in normal developing infants within the first 14 months of life (Section 1.3.1). 
Averages were constructed in three age groups (1-4, 5-8 and 9-14 months) to investigate 
whether obligatory, MMN and novelty auditory ERP components are measurable and 
whether the latencies change with increasing age. Afterwards the latencies and amplitudes 
of the obligatory, MMN and novelty ERPs of the three age groups were compared.
As a second step group mean averages of ERP waveforms were compared by constructing 
group averages across the same groups (1-4, 5-8 and 9-14 months) in infants with IS to 
investigate whether obligatory, MMN and novelty auditory ERPs are measurable (Section 
1.3.1.1). These group mean averages were then visually compared to the group averages
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recorded in normal controls to investigate whether infants with IS show differences in their 
auditory ERPs. If infants had not already been investigated and examined at the referring 
hospitals they were investigated at GOS including an EEG, MRI head scan and if 
appropriate a metabolic (infectious) workup for an underlying metabolic or infectious 
aetiology (Appendix 3). Professor Brian Neville or Dr Rod Scott supervised the clinical 
examination and investigations.
The clinical data of the patients with IS in terms of age of seizure onset, response to 
treatment (seizure control after 2 weeks), development before the onset of spasms either 
being normal or delayed, abnormal MRI (symptomatic)/normal MRI (cryptogenic) were 
related to initial ERPs at presentation and outcome at 2 years to assess the predictive value 
of these factors on initial ERP and developmental assessment outcome at 2 years (Section
1.3.1.5).
Whenever possible, recordings in infants with IS and controls were made in both 
wakefulness and sleep (Section 1.3.2.1). The ERP findings were analysed separately 
according to state. The latencies and amplitudes of the obligatory and novelty components 
in both states were then compared between the two groups.
It is difficult to decide whether the infantile ERP peaks can be regarded as analogous to any 
of the child and adult ERP peaks (Section 1.3.2.2). Some conclusions could however be 
made on similar stimulus paradigms and decreasing latencies of similar ERP components.
2.9. Statistics
SPSS version 11 (Chicago, Illinois) was used for all the statistical analyses. A repeated 
measures ANOVA was used to assess the effect of age upon latencies and amplitudes of 
various components of the ERPs effects after adjustment for hemisphere, state of awareness 
and gender in the control subjects. The ERP components investigated were the PI 50, N250, 
P350, fP250, AP250, N250, P500, Ncl, Nc2 and NcS.
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As data were not normally distributed, non-parametric ANCOVA correlations were carried 
out, when comparing the control subjects and the children with infantile spasms, after 
adjustment for age. Differences in ERP components in children with infantile spasms 
compared to control subjects, after adjustment for age were investigated.
Spearman correlation coefficients were used in the investigation of relationships between 
ERP latencies and clinical factors such as normal or abnormal development before seizure 
onset, normal or abnormal development at outcome at 2 years of age normal or abnormal 
MRI brain scans and EEG abnormalities such as presence of hypsarrythmia, moderate or 
severe EEG abnormality, persistent focal changes, exacerbation of EEG abnormalities by 
sleep and ictal recordings of infantile spasms.
For data reduction purposes the following ERP components were averaged separately for 
latency and amplitude as following: PI50 at electrodes F3, F4, C3 and C4; N250 at 
electrodes F3, F4, C3 and C4; P350 at electrodes F3, F4, C3 and C4; fP250 (P2a) at 
electrodes F3, F4 and Fz; flP250 (P2b) at electrodes F7 and F8; N2 at electrodes Ml, M2, 
P7, P8, C3, C4, and Cz; P500 at electrodes Ml, M2, P7and P8; Ncl at electrodes F3, F4 and 
Fz; Nc2 at electrodes F7 and F8 and NcS at electrodes C3, C4 and Cz.
In order to investigate the relationships between any ERP component being identified, the 
SNR and the presence or absence of infantile spasms logistic regression analyses 
were carried out.
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CHAPTER 3: RESULTS
3.1. ERPs in Control infants
Thirty-two healthy infants including 14 boys (170 +/-90 days) and 18 girls (251 +/- 
11 ldays) were recruited.
3.1.1. Mismatch-Negativity (MMN)
MMNs were analysed by comparing the standard and deviant AERPs as a subtraction 
waveform, constructed by subtracting the standard ERP from that of the deviant ERP. The 
MMN had to be greater than the average baseline voltage by 1.0 pV (Section 2.7.2). The 
group mean average of the 5-8 months control group showed a MMN at C4 with a latency 
of 210ms and amplitude of -2.8pV. The MMN reversed its polarity over the right mastoid 
electrode and had then positive amplitude of 3.9pV (Figure 3.1). Only two individual 
control infants of the 5-8 months group also showed a MMN. The MMN of the two 
individual infants at C4 with a latency of 220ms were -1.4 and -7.6pV and 1.7pV and 
13.59pV respectively at M2 (Figures 3.2 and 3.3). The high MMN amplitude of -7.6pV at 
C4 and 13.59pV at M2 for the second individual remain unexplained. There is no evidence 
that this is an artefact arising from recording or processing these data or that another 
component has been misidentified as the MMN in this particular case.
3.1.2. Signal to noise ratio
Before analysing the ERP data in IS with an abnormal background EEG activity a crucial 
first step was to determine the background EEG activity and ERP signals in normal infants 
during wakefulness and sleep. Together with a consultant neurophysiologist the average 
amplitude of background EEG activity (regarded as noise) was estimated in control infants
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to be +/-30 pV during wakefulness and +/-50 pV in stage 2 sleep. Therefore in this study 
assuming a novelty ERP signal of 30pV (50pV in sleep) amplitude, measured from peak to 
peak (P-to-P) and using the formula (Section 2.6) at least 16 responses whilst being awake 
and 16 responses during sleep were required to achieve an SNR of 2 (Section 2.6). The P- 
to-P amplitude of the obligatory ERPs was of 7pV (10 pV in sleep). Therefore at least 324 
responses during wakefulness and 400 in sleep were required to obtain an acceptable SNR 
of 2.
3.1.3. Obligatory ERP responses
3.1.3.1. ERP waveforms
In order to describe positive and negative deflections in the obligatory responses group- 
average ERPs to frequent standard stimuli were computed. Figures 2.1 and 3.4 show the 
mean group-average of 9-14,5-8 and 1-4 months respectively in wakefulness and sleep at 
electrode F3. Two prominent positive peaks were observed, the first (labelled P150) was 
separated from the second positive peak at 350 ms (here labelled P350) by a low-amplitude 
negative deflection at approximately 250 ms (N250). The N250 in the 1-4 months group 
was not as prominent as in older groups. The P I50, N250 and P350 appeared to have higher 
amplitudes during sleep. The topographical distribution of ERP component amplitudes 
PI50 and P350 showed an inversion of polarity across the anterior-posterior axis (Figure
3.5). The components were replicable within and between subjects in both wakefulness and 
sleep. Figures 3.6 and 3.7 and figures 3.8 and 3.9 are showing the replicability of the 
obligatory components PI50, N250 and P350 during 2 consecutive recordings at electrode 
F3 during wakefulness and sleep respectively.
3.1.3.2. Age dependency
With increasing age all 3 components including the PI50, N250 and P350 were measured 
reliably and were present in 76% of infants during sleep and 84% during wakefulness 
(Table 3.1).
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Controls
(N=30) Awake Asleep
P 150 26/26 100% 30/30 100%
N 250 22/26 84% 23/30 76%
P 350 22/26 84% 23/30 76%
Table 3.1 Presence of obligatory components 
P150, N250 and P350 in control infants
Using a repeated measure ANOVA a possible dependence of these components on age was 
investigated. The latencies of the components P150 (pcO.OOl), N250 (pcO.OOl) and P350 
(pcO.OOl) shortened significantly with increasing age irrespective of arousal state (Figure 
3.10). There were no significant age related changes in P150, N250 and P350 amplitudes 
(Tables 3.2, 3.3 and 3.4).
Further analyses were carried out to determine whether the age dependency was modified 
by state of arousal, gender and hemispheric side the ERP was obtained from.
3.1.3.3. Effect of arousal, side and gender
The age related effects described above were influenced by state of arousal and hemisphere. 
PI50 (pcO.OOl), N250 (p<0.004) and P350 (pcO.OOl) component latencies showed shorter 
peak latencies and PI 50 was of lower amplitude (p=0.013) during wakefulness compared to 
sleep (Tables 3.2, 3.3 and 3.4). Peak latencies of the PI 50 were consistently shorter over the 
right hemisphere compared to the left, independently of age and state of arousal (pc0.031). 
There were no gender differences.
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3.1.4. Novelty ERP
3.1.4.1. ERP waveform during wakefulness
In order to describe positive and negative deflections in the novelty responses group- 
average ERPs to novel stimuli were also computed. The group mean ERP waveforms to 
novel sounds showed large amplitude negative components over bilateral inferior temporal 
and mastoid electrodes (labelled N250) with a polarity inversion over central regions 
(labelled P250C, Figures 2.2 and 3.11). In addition the frontal P250 components (P250F) 
with different topography to those above showed an inversion of their polarity over the 
parietal electrodes. Double peaks of the P250 and N250, the early P250 (eP250), late P250 
(1P250), early N250 (eN250) and late (1N250) were seen in some individual infants at 
frontal (F3, F4), central (C3, C4), mastoid (Ml, M2) and inferior temporal (P7, P8) 
electrodes respectively. The frontal eP250F inverted its polarity with the eN250 over the 
inferior temporal electrodes bilaterally. Figure 3.12 shows this inversion on the R 
hemisphere between electrodes F4 and P8. Positive slow components (P500) were seen in 
bilateral mastoid and inferior temporal electrodes (Figure 2.2). Further long-latency 
negative waves (labelled Ncl and Nc2) were visible over the fronto-central midline and 
more prominently with longer latencies over dorso-lateral frontal regions (F3, F4, F7, F8) 
showing an inversion of the Ncl over the parietal electrodes (Figures 2.2 and 3.13).
The components were replicable within and between the subjects during wakefulness. 
Figures 3.14 and 3.15 are showing the replicability of the novelty components N250 and 
P500 in 2 individual infants during two consecutive recordings at electrode Ml during 
wakefulness.
3.1.4.2. ERP waveform during sleep
Large amplitude novelty ERPs were also recorded during sleep in all age groups (Figure 
2.3). The central P250 components (Figure 3.16) at central electrodes (C3, C4) and the 
frontal P250 components (Figure 3.17) at frontal electrodes (F3, F4) had a polarity
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inversion with N250 components over inferior temporal electrodes (Ml, M2) and parietal 
electrodes (P3, P4) respectively. In addition to the peaks identified during wakefulness 
(Figure 2.2) there was an inversion of polarity between a prominent negative wave (NcS), 
visible at the vertex and the P500 across inferior temporal, mastoid leads (Figures 2.3 and 
3.18). These NcS components were also visible over C3 and C4 electrodes (Figure 2.3), but 
with a smaller amplitude. The sleep components Ncl and Nc2 were visible over the 
electrodes F3, F4 and F7 and F8 respectively.
The components were replicable within and between the subjects. Figures 3.19 and 3.20 are 
showing the replicability of the novelty components N250 and P500 in 2 individual infants 
during two consecutive recordings at electrode Ml during sleep.
3.1.4.3. Age dependency
The latencies of the P500 (pcO.OOl), Ncl (pcO.OOl) and Nc2 (pcO.OOl) decreased 
significantly with age irrespective of arousal state (Table 3.5, 3.6 and 3.7). Figure 3.21 
shows the decreasing latency of the P500 at electrode Ml during both wakefulness and 
sleep.
Further analysis was carried out to determine whether there was an age dependency of these 
and other component latencies modified by state of arousal, gender and hemisphere the ERP 
was obtained from.
3.1.4.4. Effect of arousal, side and gender on component latencies
The latency of the P250F (Figure 3.22, p=0.024) component was only found to decrease 
with age during wakefulness (Table 3.8). The latencies of the P250F (p=0.01) were also 
shorter during wakefulness compared to sleep, but the shorter latencies were mainly seen in 
the 1-4 and 9-15 months (p=0.032, Table 3.8).
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In contrast to the peak latencies of the obligatory components PI 50 and P350 and also the 
novelty component P250, the novelty ERP components P500 (pcO.OOl), Ncl (pcO.OOl)
and Nc2 (pcO.OOl) were shorter during sleep than wakefulness (Tables 3.5, 3.6 and 3.7). 
There were also differences in novelty ERP peak latencies between the left and right 
homologous electrodes, most pronounced during wakefulness: longer P500 (p=0.005) 
latencies were observed in all age groups on the left compared to the right hemisphere 
(Table 3.5). During sleep this significant side difference was not present (p=0.013, Figure 
3.23).
The latencies of the Ncl were longer on the left hemisphere independent of arousal (Table
3.6). No effects of gender or interactions of gender and age were found on any ERP 
component latency.
3.1.4.5. Effect of arousal, side and gender on component amplitudes 
Amplitudes of all novelty ERP components tended to be larger during sleep than 
wakefulness. This was significant for the amplitudes of P250 (p=0.002), P500 (pcO.OOl) 
and Ncl (pc0.002, Tables 3.8, 3.5, 3.6). Figure 3.24 shows the amplitudes of the late 
negative Ncl waves over frontal electrodes during wakefulness and sleep.
Amplitudes of all novelty ERP components showed non-linear age-dependencies during 
wakefulness, significantly for P250 and N250 (Tables 3.8 and 3.9). Maximum peak 
amplitudes were found in the 5-8 months group compared with both the younger and older 
groups (Tables 3.8 and 3.9). N250-P250 peak-to-peak amplitudes were thus plotted Figure 
3.25), also showing a maximum in the 5-8 months group. There were significantly larger 
amplitudes over the L compared to the R hemisphere (F (2, 23) =5.6, p=0.011). The N250 
(F (1,24)=11.1, p=0.003) and P500 (F (1,23)=4.9, p=0.038) amplitudes were also 
significantly larger over the left side compared to right during wakefulness (Tables 3.5 and
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3.9). No effects of gender or interactions of gender and age were found on any ERP 
component amplitude.
3.2. Infants with infantile spasms
After the analysis of the ERPs in the control infants the clinical- and ERP data of the infants 
with IS were analysed and compared to the normal infants.
3.2.1. Demographical data
34 infants with infantile spasms including 11 girls and 23 boys were recruited. Only 28 
infants, including 18 boys (222 days +/-110 days) and 10 girls (248 days +1-96 days) were 
finally included as 3 patients (two male and one female infant) with inadequate recordings 
due to technical difficulties had to be excluded. The 3 infants excluded were recorded with 
electrode caps, which were repeatedly taken of by the infant. Because patients were 
admitted to the study as quickly as possible it was later agreed that three further patients did 
not have infantile spasms: one male infant who was thought to have IS was excluded when 
the diagnosis of Dravet syndrome was made later, two infants with TS, who had been 
referred to Great Ormond Street Hospital were recorded before a complete history was 
taken and both were excluded, as there was only a history of complex partial seizures 
(Table 3.10).
3.2.2. Seizure onset o f infantile spasms
An early seizure onset of less than 4 months is reported to be associated with a worse 
developmental outcome and we determined the seizure onset of infantile spasms in each 
individual patient by parental interview. Fifteen patients had a seizure onset of infantile 
spasms at less than 120 days (4 months) of age and thirteen patients had a seizure onset 
after 4 months of age (Table 3.10). Before the onset of infantile spasms, 5 patients had 
tonic-clonic seizures and 8 had partial onset seizures.
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3.2.3. Response to drug treatment
Ten patients were treated with Vigabatrin, four with corticosteroids and fourteen patients 
were treated with a combination of at least 2 drugs, including either Vigabatrin or steroids. 
Six patients had no seizures within 2 weeks of beginning of treatment and twenty-two 
continued to have seizures (table 3.10).
3.2.4. EEG abnormality o f the research EEGs
All patients referred to GOS were already on treatment and had had already a routine EEG 
compatible with the diagnosis of IS before the research EEG for the auditory ERPs was 
recorded. 24 patients were recorded in wakefulness and sleep and 2 patients either during 
wakefulness or during sleep. The research EEGs showed that during wakefulness 11 
patients had moderately abnormal EEG (Figure 3.26) and 15 patients had a severely 
abnormal EEG (Figure 3.27). Hypsarrhythmia was seen in only one patient and 3 patients 
had clinical spasms during wakefulness.
During sleep 9 patients had a moderately abnormal EEG (Figure 3.28) and 17 patients had a 
severely abnormal EEG (Figure 3.29). 4 Patients had hypsarrhythmia (Figure 3.30) and in 8 
patients the EEG became more disorganized in sleep. 11 patients had no focal discharges 
and 7 patients had multi-focal discharges during wakefulness.
10 patients had no focal discharges and 8 patients had multi-focal discharges during sleep. 2 
patients had left focal and further 2 had right focal discharges in both states of awareness 
(Table 3.11).
3.2.5. MRI brain scan results
One consultant paediatric neuroradiologist reviewed the MRI brain scans of 27 patients 
separating between cryptogenic and symptomatic aetiology (Table 3.12). One patient with 
trisomy 21 has had no brain scan. Eight patients were reported to have normal MRI scans.
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The abnormal MRI scans included three patients with tuberous sclerosis, seven patients 
with cortical dysplasia (Aicardi-Syndrome, Lissencephaly, Proteus syndrome, cortical 
dysplasia of right inferior parietal lobule extending into the angular gyrus region, cortical 
dyplasia of the left occipital and posterior parietal and temporal occipital region, cortical 
dysplasia of the L parietal region and one patient with an abnormal L sylvian fissure) and 
six infants with hypoxic ischaemia changes. The lesions in these six infants included one 
right middle cerebral territory infarct, one periventricular leukomalacia associated with IVH 
grade II, one gross white matter loss and porencephaly of the right frontal lobe, one subtle 
basal ganglia changes and a further patient with extensive generalized hypoxic changes to 
the occipital lobes bilaterally. One patient showed delayed myelination and in one further 
patient there was absence of the corpus callosum.
3.2.6. Development before seizure onset of IS
6 infants with an onset of IS between three and four months of age and two infants with IS 
with an onset between 4.5 and 6 months have had age appropriate development reported by 
history prior to seizure onset (table 3.10). Only one of these 6 infants had an abnormal MRI 
head scan showing widespread cortical tubers and subependymal nodules consistent with 
TS and a large tuber in the R orbitofrontal region (table 3.12).
3.2.7. SNR and EEG abnormalities in infants with IS
In infants with infantile spasms the signal may have to be extracted out of a background 
with a high degree of diffuse slow waves, spikes and sharp waves (Niedermayer and Lopes 
Da Silva 1999). This abnormal background activity may consequently diminish the SNR 
(table 3.13).
3.2.7.1. SNR calculations during wakefulness and sleep
Taking the number of possible stimuli in a stimulus block into consideration a SNR of 2 
was thought to be sufficient to extract the novelty ERP signal or obligatory ERP response.
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For the majority of the patients with a background activity of up to ±75 pV during 
wakefulness 100 responses were required to obtain a novelty signal with a SNR of 2.0. In 
sleep 162 responses (background up to 150pV) were required for a SNR of 2 (Tables 3.14 
and 3.15).
At least 1849 responses during wakefulness (3600 during sleep) were required to obtain the 
signal of the obligatory responses with an SNR of 2. In general a background activity of > 
lOOpV (150 pV in sleep) was anticipated to yield a low SNR (Tables 3.14 and 3.15).
It was then important to show any association between the SNR and the presence or absence 
of ERP components.
3.2.8. Presence of obligatory components
The first obligatory component, the P I50 was detected in 50 % of infants with IS in both 
wakefulness and sleep compared to control subjects (100 %), while all 3 components (PI 50, 
N250, P350) were seen only in 34 % (84% in control subjects) during wakefulness and 
during sleep 23% (76% in control subjects, Table 3.16).
3.2.9. Presence of novelty components
During sleep novel components (N250 at electrodes Ml, M2, P7, P8, C3, C4, and Cz; P500 
at electrodes Ml, M2, P7and P8) were present in 16/26 (61%) of infants with IS compared 
to control subjects in 29/30 (96%), while during wakefulness novelty ERP were only 
present in 11/26 (42%) compared to control subjects 23/26 (88 %, Table 3.16).
3.2.10. Presence of obligatory components and SNR
After adjusting for the SNR using logistic regression controls were 5 (95% Cl: 1.1 to 24.3) 
times more likely to have all components identified than patients with IS during 
wakefulness (p=0.04). 21/26 controls have all components compared to 9/25 patients. After
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adjusting for the SNR during sleep there was no difference between patients and controls in 
terms of the proportions with all components identified (p=0.3). 23/31 controls have all 
components but only to 6/26 patients.
3.2.11. Presence of novelty components and SNR
After accounting for the effect of SNR, the control subjects were 4.4 (95% Cl: 0.85 to 23.2) 
times more likely to have all novel components detected than patients with IS (p=0.08) 
during wakefulness. The chance of identifying all components is increased by 1.6 (0.94 to
2.7) times for every increase in SNR of 1 unit (p=0.08).
After adjusting for the effect of SNR the control subjects are 9.6 (95% Cl: 0.86 to 106.7) 
times more likely to have all components detected than patients with infantile spasms 
(p=0.07) during sleep.
3.2.12. Presence or absence of ERPs during wakefulness or sleep in infants with IS 
dependent on the degree of EEG abnormality
There was a relationship between the presence of obligatory components and the severity of 
the EEG abnormality in wakefulness (p=0.005) and in sleep (p=0.004). There was also a 
relationship between presence of novelty components and the severity of the EEG during 
wakefulness (p=0.02) and sleep (p=0.03). These results showed that less components are 
seen with worsening EEG activity (Table 3.17).
3.2.13. Obligatory ERP responses
In order to describe positive and negative deflections in the obligatory responses 
of infants with IS group mean average ERPs to frequent standard stimuli were computed. 
Two positive components labelled PI 50 and P350 were separated by the negative 
component N250. The obligatory components were replicable within and between subjects 
in both wakefulness and sleep (sect ref 2.7). Figures 3.31 and 3.32 and figures 3.33 and 3.34
79
are showing the replicability of the obligatory components PI 50, N250 and P350 during 
wakefulness and the PI 50 during sleep in 2 consecutive recordings at electrode F3 
respectively.
Figures 3.35, 3.36 and 3.37 show mean group ERPs at the 1-4, 5-8, and 9-14 months in 
infants with IS compared to controls at electrode F3 in wakefulness and sleep respectively. 
The latencies of the PI50, N250 and P350 appeared prolonged during sleep in the 5-8 and 
9-14 months of infants with IS (Figures 3.36 and 3.37). The 1-4 months group appeared to 
have similar latencies compared to control group, but there was only one patient in the 
group of infantile spasms (Figure 3.35). The P150, N250 and P350 latencies of the 9-14 
month group with IS appeared to be longer compared to the control group during 
wakefulness (Figure 3.37). On the contrary the latencies of the 1-4 and 5-8 months groups 
with IS appeared to have similar latencies to the control groups, but there were only 2 
patients during wakefulness in the mean group averages of the infants with IS at 1-4 months 
(Figures 3.35 and 3.36).
The next figures are taken as examples to demonstrate individual infants with presence or 
absence of the obligatory components. Figure 3.38 shows an infant with infantile spasms 
aged 10 months during wakefulness with prolonged PI 50, N 250 and P350 components 
compared to the control group 9-14 months and figure 3.39 shows an infant aged 10 months 
with only a PI50 component compared to the control group 9-14 months.
3.2.14. Novelty ERP responses
In order to describe positive and negative deflections in the novelty responses group mean 
average ERPs to novel stimuli were also computed. The novelty ERP components described 
in the control group during wakefulness (3.1.4.1) and sleep (3.1.4.2) were also detected in 
infants with infantile spasms. The novelty components were replicable within and between
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subjects in both wakefulness and sleep. Figures 3.40 and 3.41 and figures 3.42 and 3.43 are 
showing the replicability of the novelty components N250 and P500 during 2 consecutive 
recordings at electrode Ml during wakefulness and sleep respectively.
The positive and negative components of the infants with IS had longer latencies compared 
to the control infants during wakefulness or sleep. Figures 3.44, 3.45 and 3.46 show group 
mean ERPs at 1-4, 5-8 and 9-14 months in infants with IS compared to controls during 
wakefulness and sleep at electrode Ml respectively. The latencies of the N250 and P500 of 
the IS group ERPs appeared to be prolonged compared to the control group in both states of 
awareness. Prolonged Ncl and Nc2 latencies of group mean ERPs at 5-8 months in infants 
with IS compared to controls are shown at electrodes F3 and F4 in figure 3.47 during 
wakefulness.
There were not enough infants with IS to compute group mean averages of a similar age 
range and aetiology (Tables 3.11 and 3.12). The next figures have been selected to 
demonstrate that patients with unilateral abnormal hemisphere pathology have abnormal 
novelty ERPs in both hemispheres.
Figure 3.48 shows a 10 months old infant with a R middle cerebral territory infarct, which 
has been recorded only in sleep. The N250 and P500 latencies are prolonged at the mastoid 
(Ml) and inferior temporal (P7) electrodes of the L hemisphere compared to the mean 
average of the 9-14 months control group. Despite normal N250 and P500 latencies on the 
R hemisphere, amplitudes of both components are reduced.
Figure 3.49 shows N250 and P500 latencies at electrode P8 (right hemisphere) and P7 (left 
hemisphere) in an 8 months old infant with a R cortical dysplasia in sleep, which are 
prolonged compared to averaged group ERPs for 5-8 months in control infants.
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3.2.15. Latency differences between the IS and control ERP
As it was not possible to adequately transform the ERP data of the IS to normality, 
nonparametric ANCOVA calculations were carried out to compare the amplitudes and 
latencies with control subjects. The latencies of the PI 50, N2, P3 and Nc2 (p<0.001) and 
the Ncl (p<0.0001) in infants with IS were still prolonged when compared to control 
subjects after adjustment for age during wakefulness (Table 3.18). During sleep the P150, 
P3 and the specific sleep component NCS (p<0.001) and the N250 (p<0.008) were also 
prolonged significantly after adjustment for age when compared to controls (Table 3.18).
3.2.16. Assessment of possible associations between ERP latencies and clinical factors 
Using Spearman correlation coefficients no relationships between ERP latencies and 
clinical factors such as normal or abnormal development before seizure onset, normal or 
abnormal MRI brain results and EEG abnormalities such as presence of hypsarrythmia 
during sleep, moderate or severe EEG abnormality, persistent focal changes, exacerbation 
of EEG abnormalities by sleep, ictal recordings of infantile spasms met the criteria for 
significance having a p-value of less than 0.05.
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CHAPTER 4: DISCUSSION OF RESULTS IN 
HEALTHY INFANTS
A critical part of this study was to obtain reliable and replicable ERP data in normal infants 
in order to assess the functional integrity and possible maturation of the temporal lobe and 
to allow comparison with infants with infantile spasms.
4.1. Obligatory ERP responses
4.1.1. ERP components
There is currently no published cross-sectional study comparing auditory ERP latencies in 
normally developing infants during wakefulness and stage II sleep. In this study, a small 
negative deflection (N250) was found between two positive deflections called PI50 and 
P350. The P350 was followed by a further negative deflection labelled N450. These 
components were seen in both wakefulness and stage II sleep. Although the N250 and P350 
components were already seen within the first 4 months of age their peaks became more 
clearly separable with increasing age. This ERP component structure is in agreement with 
previous studies (Section 1.2.3.1.1.2, Kushnerenko et al., 2002a; Jing et al., 2006). The 
topographical distribution of ERP components PI 50 and P350 showed a clear inversion of 
polarity across the superior temporal plane, best explained by a generator in the superior 
temporal gyrus.
4.1.2. Age dependence of ERP peak-latencies
In our study the latencies of the PI 50, N250 and P350 significantly decreased with 
increasing age independent of arousal. This is in agreement with the study by Jing et al 
(2006), but contrasts with the study by Kushnerenko et al (2001) where only the P150
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latency was reported to decrease with increasing age. The decreasing latencies with age 
may be evidence of a continuing maturation process in the temporal lobe of normal infants.
4.1.3. Effect of sleep on obligatory components
The latencies of the PI50, N250 and P350 also decreased with increasing age significantly 
during stage II sleep, but were significantly longer than those measured in wakefulness.
This result clearly shows that auditory ERP latencies in infants are dependent on the state of 
arousal and therefore when analysing auditory ERPs it is particularly important to 
distinguish between different states (Section 1.2.4). There are no infant studies for 
comparison, but studies in adults have also shown an increase in the latency of the 
obligatory components during stage II sleep (Nielsen-Bohlman et al, 1991; Atienza et al. 
2001; Crowley et al., 2004). The present data suggest that the cerebral generators for the 
P I50, N250 and P350 components are already present within the first 4 months of 
extrauterine life and that ERP components are identifiable during both wakefulness and 
sleep.
A reason for the delayed latencies during sleep may be the fact that during stage II of non­
rapid eye movement (NREM) sleep thalamocortical neurons are also globally inhibited by 
increased GABA (y-aminobutyric acid) input from the thalamic reticular nucleus, resulting 
in much lower firing rates compared to wakefulness. This inhibition is partly modulated by 
the cholinergic and aminergic neurotransmitter systems in the pontine reticular formation. 
During wakefulness the pontine aminergic system is tonically activated and inhibits the 
pontine cholinergic system. During NREM sleep the aminergic inhibition decreases and the 
cholinergic excitation waxes (Pace-Schott et al., 2002). The longer latencies of the PI50 
N250 and P350 in stage II sleep may then be secondary to different levels of energy 
metabolism in cortical neurons. PET studies of NREM sleep have shown a decreased 
cortical and thalamic energy metabolism and blood flow compared to wakefulness and
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rapid-eye movement (REM) sleep. The energy metabolism during sleep decreases 
progressively with greater depth of NREM sleep (Pace-Schott et al, 2002).
4.1.4. Are the infantile ERP peaks analogous to any childhood or adulthood peaks?
In the absence of an extensive developmental study using serial recordings no definite 
answer can be given, but each component will be discussed separately.
4.1.4.1. The infantile P150 as a possible precursor of the adult P50
The ERP (P150-N250-N450 complex) in the first 12 months of life identified in this study 
and by Kushnerenko et al (2002) is similar to the complex P100-N250-N450 recognized in 
children (Paetau et al, 1995; Ceponiene et al., 1998; Ceponiene et al, 2002a). A persisting 
peak of the PI 50 with decreasing latency during infancy (this study, Kushnerenko et al, 
2002) and further decreasing latency between infancy and 5-6 years suggests that the PI 50 
is the precursor of the childhood P100. The P100 develops into the adult P50 (PI) response 
by further decreasing latency from 5 to 20 years (Ponton et al, 2000).
4.1.4.2. The infant N250 as a correlate of the of the childhood N250
In this study the latency of the infantile N250 decreased significantly over the first 14 
months of age and may therefore be regarded to be the correlate of the childhood N250. The 
N250 gradually matures into the adult N2 from 5 to 20 years of age (Ponton et al., 2000). 
The latency of the N250 has been reported to shorten with age but mainly from 9 years to 
adulthood without shortening between 4 and 9 years of age. The N250 amplitude is reported 
to decrease steadily with age, but continues to have a similar scalp distribution until 
adulthood and therefore the childhood N250 is suggestive of corresponding to the adulthood 
N2 (Ceponiene et al, 2002b).
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4.1.4.3. The infantile P350
The adult P2 appears to mature early, at around 5 years of age, since latencies did not 
change between 5 and 20 years of age (Ponton et al., 2000). Whether the infantile P350 
corresponds to the adult P2 remains unclear in the absence of a detailed developmental 
study of this component.
4.2. Endogenous ERP responses
4.2.1. Mismatch-negativity
The MMN as a possible tool was assessed, but was only shown in the group mean average 
of the 5-8 months group. An anticipated adverse SNR in infants with IS and the fact that the 
MMN was not reliably detectable in individual control infants were the reasons why the 
MMN could not be used as a tool to assess the temporal lobe function in infants with IS.
4.2.2. Novelty ERP components
Previous developmental ERP studies have utilized different numbers of electrodes and 
recording montages and have not commented on possible generators (Table 1.1). There is 
therefore a paucity of information on developmental changes in ERP topography that could 
provide insight into the functional maturation of specific cortical regions. This study used 
19 electrodes and also commented on possible generators and the distribution of the ERPs. 
Novel sounds elicited prominent fronto-central “P3a” like responses of positive polarity 
(P250), and large amplitude negative components over bilateral inferior temporal and 
mastoid electrodes (1N250). Double peaks of the “P3a”, the early P3a (eP3a) and the late 
P3a (IP3a), which are clearly separable during childhood (Ceponiene et al., 2004) and 
adulthood (Escera et al., 1998) were seen only inconsistently at frontal and central 
electrodes and were therefore not measured in all infants. In individual infants, where the 
eP3a and IP3a were separable, the early P3a clearly inverted its polarity over the mastoid 
and inferior temporal electrodes. However the finding that the late P3a did not invert its 
polarity at any electrodes, is in agreement with the adult (Escera et al., 1998) and childhood
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literature (Gumenyuk et al, 2001). The lack of consistency of these early and late 
components might be due to physiological maturation in infants up to one year of age. The 
ffonto-central distribution of the P250, the double peaks and the significant larger amplitude 
compared to deviants are supporting evidence of the P250 being the precursor of the adult 
P3a. Following the positive “P3a” component, novel sounds elicited robust slow 
components (P500) bilaterally in inferior temporal leads. Further components are fronto- 
central negativities, previously termed Nc, lasting from 500 to 1400 ms after stimulus onset. 
So far the Nc component has only been shown in infants using visual ERP (Courchesne et 
al, 1981). In this study two components were clearly separated in individual and group 
mean averages: a first Ncl peak with a latency of 500-1000 ms, and a second Nc2 peak at 
1000-1400 ms. Two Nc components have also been found in children between 9 and 13 
years of age showing peak latencies between 400-750ms and 800-1100ms (Ceponiene et 
al., 2004). The Ncl and the Nc2 components had opposite polarity at the parietal electrodes.
The “P3a” (P250) and negative (N250) components over both hemispheres showed an 
inversion of their polarity between mastoid (inferior temporal) and central electrodes, 
compatible with a generator site within the posterior superior temporal plane. This inversion 
is also seen between the positive P500 and the central component (NcS) bilaterally at the 
same electrodes. The frontal “P3a” (P250) components showed an inversion of their 
polarity over the parietal electrodes suggesting that their generator is more anteriorly 
located to the superior temporal plane. The presence of a P3a generator in the superior 
temporal gyrus is supported by the study by Alho et al (1998), which identified a generator 
of the magneto-encephalographic P3 in the superior temporal plane in adults. These 
findings, indicating two or more generators within the superior temporal plane and a further 
generator within the frontal lobe, are consistent with a neural network consisting of several 
generators as suggested by intracranial recording studies in adults (Halgren et al, 1995a; 
Halgren et al, 1995b; Baudena et al, 1995).
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4.2.2.1. Effect of sleep on novelty processing
The P250, N250 and P500 were clearly seen during stage II sleep. These findings strongly 
support the concept of auditory novelty processing in sleep stage II in infancy and are 
consistent with findings in adults (Atienza et al., 2001). The central P250 components and 
frontal P250 components showed also a polarity inversion with the N250 over the mastoid 
and parietal electrodes. Two frontal negative components labelled Ncl and Nc2 over the 
frontal electrodes and a further central component, labelled NcS, (peaking 80ms earlier than 
the Ncl and seen only over the central electrodes C3, C4 and Cz) seen in the present study 
may reflect further novelty processing during sleep stage II. The central NcS components 
showed a reversal of polarity with the P500 across inferior temporal leads (Section 3.1.4.2) 
while the frontal Ncl and Nc2 showed a reversal of their polarities over the parietal 
electrodes P3 and P4 and Pz respectively. These findings are also consistent with a neural 
network consisting of multiple generators.
The distributions and latencies of the novelty components were similar in both wakefulness 
and sleep. The larger amplitudes of the novelty amplitudes during sleep compared with 
wakefulness have not been reported previously.
The identification of ERP components in the developing child is often problematic 
especially when comparing different states of arousal. If the components P500, Ncl and 
Nc2 seen in sleep represent the same components seen in wakefulness, then the latencies 
show a dramatic reduction, which is both unexplained and unprecedented. If they represent 
different components, this argues that the auditory signals are processed completely 
differently in wakefulness and sleep in the developing brain, a phenomenon not seen in the 
mature brain. At this stage, there are no clear additional data to indicate which of these 
possibilities is likely to be correct.
4.2.2.2. Age related latency changes of novelty ERP components
The latency of the novelty P250 decreased with age during wakefulness, while the long 
latency component P500, Ncl and Nc2 showed a more marked decrease in latency with age 
independent of arousal. These latency changes appear therefore to follow a normal 
maturational sequence.
4.2.2.3. Age related amplitude changes of novelty ERP components
The amplitudes of the N250-P250 demonstrated significant inverted-U-shaped age- 
dependencies during wakefulness, showing a maximum amplitude in the 5-8 months group. 
Similar results with maximum amplitude at 6 months using speech sounds have been shown 
by Vaughan and Kurtzberg (1992), but data from other studies using click or tone stimuli 
did not find this result (Barnet, 1975; Shucard et al, 1987b; Shucard et al., 1988). While 2 
studies (Shucard et al, 1987; Ohlrich and Bamet 1972) measured the amplitude from peak 
to peak, Vaughan et al (1992) measured the amplitude from baseline to peak. These 
different measurements may have contributed to this discrepancy. ERP peak amplitudes for 
visual evoked potentials also showed a maximum amplitude at 6 months of age (Vaughan et 
al, 1992). As the synaptic density of the visual cortex reaches its maximum around 8 
months (Huttenlocher et al, 1982), followed by a decline it has been suggested that the 
inverted-U-shaped VEP amplitude parallels the time course of synaptic density (Vaughan et 
al, 1992).
4.3. Infantile neural network for novelty
This study has provided the first evidence that the auditory detection mechanism for novelty 
is present in infants during wakefulness and sleep. This ability may already be present in 
newborns (Section 1.2.3.1.2.2). The findings of several generators are consistent with a 
neural network for novelty in infants (Section 4.2.2). Furthermore, our results have also 
shown that during stage 2 sleep interesting and surprising novel stimuli can be detected by 
the auditory system. As the ability to orient to novel events is critical for survival (Sokolov,
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1963) one may even suggest that the auditory system continues preserving this “essential 
service” during sleep in order to maintain contact with the surrounding environment. This 
essential service may also protect from danger in the environment.
4.4. Hemisphere dependence of obligatory and novelty ERP latencies and amplitudes
The peak latency of the P I50 was shorter over the right than the left 
hemisphere, irrespective of age and arousal. This is in contrast to the findings of Jing et 
al (2006) who detected a shorter P I50 latency over the left compared to the right 
hemisphere. Shorter latencies over the right hemisphere were also seen for the novelty 
component Ncl in this study. The peak latency of the P500 was also shorter over the 
right hemisphere but this effect was seen mainly during wakefulness. Although there is 
no direct corroboration of these findings, Chiron et al (1997) found a higher blood flow 
in the right hemisphere in children. The N250 was the only novelty component showing 
higher amplitudes over the left hemisphere. These disparate pieces of information open 
up the possibility that each hemisphere may have different patterns of maturation.
4.5. Neural mechanism possibly underlying the development of the obligatory and 
novelty ERPs in normal infants
The possible mechanisms underlying the maturation of infants ERPs may be divided 
into anatomical and physiological causes.
4.5.1. Anatomical causes
Postnatal cortical development during the first year of life is characterized by an increased 
synaptic density, i.e. the number of synapses per neuron, dendritic growth and an expansion 
in the total volume of cerebral cortex (Huttenlocher, 1979). There is an increased synaptic 
density in several brain regions including the auditory cortex, frontal cortex and visual 
cortex reaching a plateau around 3-9 months (Huttenlocher et al., 1987; Huttenlocher et al., 
1997). The mean synaptic density is maximal at 3 months in the primary human auditory
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cortex (Heschl’s gyrus), at 8 months in the visual cortex and in the association areas of the 
frontal cortex only by two years of age (Huttenlocher, 1990; Huttenlocher et al, 1997). 
Despite the early maximal synaptic density of the auditory cortex the anatomical maturation 
of the human auditory cortex is protracted and may be separated into three stages. During 
the first stage between the 3rd trimester and the 4th postnatal month mature axons are only 
present in the marginal layer, also called layer I, as seen by the pattern of axonal 
neurofilament expression. All other layers have no mature axons until the age of 5 months 
(Moore et al, 2001). Although infants can precisely distinguish speech sounds, there is no 
anatomical route for transmission as the auditory cortex has only mature axons in the 
marginal layer (Moore, 2002). On the contrary the results of this study are showing clearly 
ERPs generated in the cortex. During the second stage between 6 months to 5 years the 
axons in the deep cortical layers continue to mature and increase in density, but the 
superficial layers have not yet started to mature. These deep-layer axons are identified as 
thalamocortical afferents indicating that auditory connections from the brainstem and 
thalamus are emerging auditory pathways between 5 months and a year. This may be 
supported by the fact that at 6 months of age infants begin to discriminate between 
prototype and variant versions of native and non-native speech sounds (Moore, 2002). The 
maximum amplitude of the novelty ERPs at 5-8 months group during wakefulness in this 
study and in the study by Kurtzberg using speech sounds may be further evidence for this 
maturation (Section 4.2.2.3).
The third stage of anatomical maturation, which is not complete before 12 years of age or 
later, includes the axons in the superficial layers. These fibres represent corticocortical 
connections, such as commissural axons connecting both cerebral hemispheres and 
association fibres connecting the auditory cortex with the temporal, parietal and prefrontal 
cortical lobes. This late maturation is reflected in frequency resolution reaching adult levels 
by the age of six years, but temporal resolution is still developing beyond the age of 12 
years (filing, 2004).
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4.5.2. Physiological causes
Both synaptic density and the efficacy of the synapse change during development. Changes 
in synaptic efficacy during development occur both at the presynaptic terminal and at the 
postsynaptic site. The amount of transmitter available for release increases, and in addition 
transmitter quanta are released more synchronously, resulting in a faster rise of the 
postsynaptic potentials at the maturing synapse (Naka, 1964). Consequently this will result 
in decreased latencies to the initiation of an action potential (Eggermont 1988). Increasing 
myelination is a further factor contributing to the decrease in latency (Moskowitz et al., 
1983; Eggermont, 1988). An increased consistency of the brain response with age (Thomas 
and Crow 1994) resulting in a decrease of the trial-to-trial variability may also contribute to 
the shortening of the ERP peak latencies. One of the major neurotransmitter in the brain is 
y-amino butyric acid (GABA), which has excitatory properties in early life before switching 
to its predominant inhibitory functions. Currently it is not known when this switch, related 
to the post-natal maturation of the chloride transporter gene KCC2, takes place in the 
human brain (Ben Ari, 2002; Ben Ari et al. 2005).
For the reasons mentioned above the neural maturation process of ERPs is therefore very 
complex, but may give some explanations why ERP latencies seem to decrease more evenly 
over age in contrast to the non-linear changes of ERP amplitudes.
4.6. Conclusions
The obligatory and endogenous components (novelty) of the ERPs were detected reliable 
and replicable in the control infants. There was a clear age dependence of all obligatory 
components independent of arousal. The novelty components also showed an age and sleep 
dependency. It was therefore reasonable to compare these results with those in infants with 
IS.
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CHAPTER 5: DISCUSSION OF ERP FINDINGS 
IN INFANTS WITH INFANTILE SPASMS
The processing of auditory stimuli in the temporal lobe was investigated using auditory 
ERPs (Section 1.2.2), in order to test the hypothesis that the temporal lobe is functionally 
abnormal in children with infantile spasms. One of the primary aims of this study was 
therefore to compare the ERPs in infants with infantile spasms with the findings in the 
normally developing infants. In addition we investigated whether initial ERPs were 
predictive of the neurodevelopmental outcome at 2 years of age (Section 1.3.1.4). Variables 
documented here were age at seizure onset, response to treatment (seizure control after 2 
weeks), development before the onset of spasms, and MRI findings in order to determine 
whether these findings were also related to initial ERP at presentation and developmental 
outcome at 2 years. As the ERP recordings of control infants showed clear differences 
between wakefulness and sleep stage 2, we carried out these investigations in both 
wakefulness and sleep (Sections 4.1.3 and 4.2.2.1). One of the major anticipated problems 
in the analysis of the ERP data of the infants with IS was an abnormal EEG with an abnormally 
low SNR. Before discussing and interpreting the ERP findings in infants with IS in the 
context of the SNR, the literature on the possible effects of epilepsy, cortical malformations, 
AEDs, and developmental delay on auditory ERPs in infants and children will be reviewed.
5.1. Influence of epilepsy, malformations, AEDs and developmental delay on auditory 
ERPs
Epileptogenesis, organic brain damage, underlying developmental delay, AED therapy and 
clinical seizures are likely to be interrelated and may influence auditory event related 
potentials in patients with epilepsy. There are no studies in infants and only a few studies in 
children with epilepsy reporting auditory ERP findings. The P300, also called P3b, which is
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elicited only by active participation of the subject, has been studied most extensively 
(Section 1.2.3.1.2.2).
5.1.1. Influence of epilepsy and cortical malformations
A recent study of 45 patients with generalised seizures, 55 patients with partial seizures and 
20 patients with intractable seizures showed significantly longer P300 latencies in the 
intractable and partial groups when compared to 25 control subjects (Celebisoy et al.,
2005) While patients with partial or generalised seizures were taking only one antiepileptic 
drug, patients with intractable seizures were using several combinations of AEDS, which 
may have confounded the result of the prolonged latency in the intractable group. The 
influence of AEDs on the P300 latency was not studied or commented on in this study. The 
duration of epilepsy, seizure frequency and the cerebral imaging pathologies were also not 
significantly correlated with the delayed P300 latencies.
Visual and auditory event related potentials were recorded in 32 children with epilepsy with 
abnormal MRI brain scans and 18 children with normal MRI brain scans and compared to 
data of 21 normally developing children (Turkdogan et al., 2003). The mean latencies of the 
N2 (Section 1.2.3.1.1.1) and the P300 components of visual event related potentials and 
auditory event related potentials were significantly longer in all children with epilepsy 
compared to controls, but there was no significant difference in latency between children 
with epilepsy having normal or abnormal MRI head scans. The prolonged latencies were 
also not significantly related to the number of AEDs (mono-versus polytherapy). The small 
number of patients having generalised seizures did not allow comparison with the group 
having partial seizures.
Abnormal P300 latencies have also been shown in children with symptomatic partial, 
idiopathic generalised and idiopathic partial epilepsies (Konishi et al., 1995). The 
prolongation was greatest in the patients with symptomatic partial epilepsies. The latter 
group also had the largest number of children with mental retardation treated with 2
94
antiepileptic drugs, which may have contributed to the prolonged P300 latency in the group 
with symptomatic partial epilepsy. The shortening of the P3 latency with age was small in 
all three groups and different in each epilepsy syndrome compared to controls.
In summary most of these studies reported prolonged P300 latencies in patients with 
epilepsy compared to controls. Patients with partial epilepsy had longer P300 latencies 
compared to patients with idiopathic epilepsy. Although there are no published auditory 
event-related potential studies in patients with cerebral malformations without seizure 
activity, an abnormal MRI of the brain in children with epilepsy was not more significantly 
correlated with a prolonged P300 latency then a normal MRI in children with epilepsy 
(Turkdogan et al,. 2003; Celebisoy et al, 2005).
5.1.2. Influence of AEDs
In the current study all 28 infants, including 14 infants on a combination of at least 2 drugs, 
were treated with AEDs (Section 3.2.3). Only 6 patients had no seizures within 2 weeks of 
beginning of treatment. This poor response is most likely due to treatment of patients with 
IS at a tertiary referral centre. The literature on AEDs affecting ERPs is contro-versial. 
Shorter P300 latencies were found in a heterogenous group of patients with epilepsy having 
monotherapy compared to those receiving polytherapy (Triantafyllou et al., 1992). Patients 
with temporal lobe epilepsy showed no differences in P300 latencies between monotherapy 
compared to polytherapy (Fukai et al., 1990). A prolongation of the P300 latency was 
recorded in children with epilepsy undergoing monotherapy with supratherapeutic serum 
levels of carbamazepine or phenytoin (Enoki et al., 1996). One study including seventy- 
three children (age 7-15 years) with newly diagnosed epilepsy including partial and 
generalised seizures compared the auditory P300 before and 6 and 12 months after 
antiepileptic drug therapy with either carbamazepine, phenobarbital or carbamazepine 
(Chen et al., 1996). The P300 latencies were increased in children receiving phenobarbitone 
but not in children receiving carbamazepine and valproate. The P300 latencies of these 
epileptic children before treatment were not compared to children not having epilepsy.
95
Several studies exploring the effects of ACTH and corticotropin-releasing hormone on late 
auditory evoked potentials in adults have shown inconclusive results concerning 
amplitude/latency of the N1 and P2 amplitude (Hartmann et al, 1996). The P300 latency 
did not change after a single dose and prolonged intranasal administration of ACTH 
(Smolnik et al., 2000).
In summary there is little evidence that AEDs have a major effect on auditory processing 
and therefore delayed ERP latencies unless the medications were used in supratherapeutic 
doses.
5.1.3. Influence of developmental delay on ERPs
Are auditory ERP latencies also prolonged in patients with developmental delay (DD) or 
mental retardation (MR) not having epilepsy? The Down’s syndrome (DS) has been most 
often studied as an example of developmental delay. There are only two infant studies using 
click evoked ERP responses comparing sleeping normal infants with sleeping infants with 
DS (0-3,3-9 and 9-14 months) not having seizures (Barnet et al., 1967; Barnet et al., 1971). 
The so-called “N2-P2-N3” was recorded at the electrode Cz during sleep, but the sleep 
stage was not recorded. Significantly greater amplitudes of the P2-N3 component but no 
latency changes were recorded in DS compared to normal control groups (Barnet et al., 
1967). A further study using auditory clicks also showed no latency changes between 
normal control and infants with DS (Barnet et al, 1971). The different nomenclature and 
montage makes a direct comparison with this study and other studies difficult (Section 
1.2.3.1.1.2). A further study comparing normal developing infants with infants having 
Down syndrome using several electrode placements according to the 10-20 systems might 
be useful to confirm these findings. However long latency auditory event related potentials 
recorded in 12 subjects with Down syndrome aged between 11 and 19 years showed 
prolonged latencies of all components from N1 to P3 compared to normal controls of 
similar age (Diaz et al., 1995). Lincoln et al (1986) had shown similar results comparing
96
Down syndrome children with normal children. Adults with Fragile X syndrome, the most 
common form of inherited mental retardation, also showed prolonged P3 latencies (St Clair 
et al, 1987) and children with Fragile X showed no habituation of the N1 and an absence of 
N2 sensitisation for repeated tones in an auditory oddball paradigm (Castren et al., 2003). 
By contrast with studies in Down syndrome, mental retardation and Fragile X syndrome, 
the most consistent P300 abnormality in autistic patients is amplitude attenuation while the 
latency remains unaffected (Bomba et al, 2004).
In conclusion there may be some evidence that a developmental delay in infants without 
seizures is not associated with prolonged ERP latencies. On the contrary in childhood and 
adulthood there are several auditory ERP studies showing clearly the association between 
prolonged ERP latencies and developmental delay.
5.2. Auditory ERPs of infants with IS and the issue of SNR
Having presented the literature background of epilepsy, AEDS, cortical malformations and 
developmental delay as possible causes for auditory ERP latency changes, the findings of 
the infants with IS in our study will be discussed now. There was no correlation between 
any ERP components and development at presentation, EEG abnormalities or underlying 
MRI aetiology. There are currently no studies in the literature correlating auditory ERPs 
with cognitive development during childhood. Auditory ERPs may generally not have a 
correlation with cognitive development or the developmental assessment was not sensitive 
and fine graded enough to show a correlation Future studies are certainly required to 
correlate cognitive outcome with ERPs. There were significant latency differences between 
the group of infants with IS and the group of normally developing infants during 
wakefulness and sleep. The discussion of the results will be separated according to 
obligatory and endogenous components.
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5.2.1. Obligatory components
The latency of the PI50, which is the first positive component of the exogenous 
components was significantly longer during both wakefulness and sleep in infants with IS 
compared to control infants. As the PI50 is the possible precursor of the adult P50 (Section
4.1.4.1), it is suggested that the abnormal latencies of the PI50 in infants with IS are 
compatible with an auditory processing deficit in the primary auditory cortex. All three 
obligatory components were only present in 34% of infants with IS during wakefulness and 
in 23% during sleep respectively. With a severe EEG abnormality fewer components were 
present during wakefulness and sleep. After adjusting for the SNR using logistic regression 
controls were still 5 times more likely to have all components identified during 
wakefulness. However, during sleep there was no difference between patients and controls 
in terms of the proportions with all components identified.
5.2.2. Endogenous components
The latencies of the N250 and the P500, which are suggested to be generated in the 
posterior superior temporal plane (Section 4.2.2) were also significantly delayed in patients 
with IS during both wakefulness and sleep compared to controls. Although this evidence 
points to major processing deficits in the temporal lobe, both the frontal Ncl and Nc2 
components were significantly delayed during wakefulness in IS. The latency of the sleep 
component NcS was also significantly delayed compared to controls. All endogenous 
components were present in only 42 % of patients with IS during wakefulness and 61% 
during sleep. With a severe EEG abnormality fewer novelty components were identifiable 
during wakefulness and sleep. After adjusting for the effect of SNR using logistic 
regression control subjects were 4.4 times more likely to have all novel components 
detected than patients with IS (p=0.08) during wakefulness. During sleep controls were 9.6 
times more likely to have all components detected than patients with infantile spasms 
(p=0.07). This is weak indication that the differences in the detection of components are 
independent of the SNR during wakefulness.
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These data provide therefore the first indication that the absence or prolonged latencies of 
the obligatory or endogenous components may not be due to an abnormal SNR but may be 
related to abnormal auditory processing in infants with infantile spasms.
5.3. Abnormal auditory processing in the syndrome of IS
There are no other reported studies having recorded auditory event related potentials in 
infants with epilepsy, but the prolonged obligatory and endogenous latencies in both sleep 
and awake state of IS are compatible with compromised auditory processing. This study has 
shown that auditory processing is already compromised at the lowest cortical level, the 
primary auditory cortex, in infants with infantile spasms. This is supported by the abnormal 
PI50 component, which is likely to be generated in the primary auditory cortex (Section
4.1.4.1). The temporal lobe is part of the network processing auditory novelty stimuli 
(Section 1.2.3.1.2.2). The latencies of the endogenous components were abnormal over the 
frontal and temporal electrodes. The fronto-temporal system is essential for directing 
attention to novel auditory events in order to develop normal interaction with the 
environment. The absence or delayed latencies of the novelty components may therefore be 
the neurophysiological expression of a compromised auditory novelty detection mechanism 
of speech and environmental stimuli and the indifference to their surrounding. The 
abnormal ERP latencies during sleep reinforce the evidence of continued interruption of 
auditory processing.
It is not known whether antecedent auditory processing in the thalamus, midbrain and 
brainstem was also affected in our patient population. Abnormal processing in these parts of 
the auditory pathway could have had downstream effects on cortical auditory processing in 
the temporal lobe. Brainstem auditory evoked potentials (BAEPs) have been reported to be 
abnormal in up to 50% of patients with IS (Kaga et al., 1982; Curatolo et al, 1989; 
Miyazaki et al., 1993).
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These findings therefore support the main hypothesis of a dysfunctional temporal lobe in 
the syndrome of infantile spasms, but cannot exclude a dysfunction at an earlier auditory 
processing stage.
There can be no definite answer whether the infantile spasms caused the delayed ERP 
latencies due of the lack of antecedent comparable studies. There is some evidence that 
infants with Down syndrome with developmental delay, but without seizures have not 
shown delayed latencies. As the prolonged latencies in this study are also not simply due to 
an abnormal SNR, it is likely that the IS are a necessary factor compromising auditory 
processing in infants with IS. In order to further support this hypothesis, it would, however, 
be essential to record infants with a high risk of developing IS both before and after the 
onset of spasms. Infants with TS, in which IS are common would be an ideal group to 
study. A study recording auditory event-related potentials in infants having other epilepsy 
syndromes then IS will further help to determine if the delayed latencies are specific for the 
syndrome of infantile spasms.
The possible effect of AEDs on auditory ERPs in infants with IS especially are unknown as 
there can’t be studies comparing infants having epilepsy on AEDs with normal controls on 
AEDs. Nevertheless it may be possible to record ERPs in infants with IS before treatment 
with AEDs. Only supratherapeutic doses or polytherapy with AEDs seem to have affected 
auditory processing in children with epilepsy.
There was also no correlation between an underling MRI abnormality and auditory ERPs in 
this study, but the latencies or amplitudes were prolonged on both hemispheres in the 
individual patients with an underlying cortical dysplasia or middle cerebral territory infarct 
(Section 3.2.15). Therefore it is likely that the infantile spasms may have contributed to the 
prolonged latencies or reduced amplitudes on the hemisphere without MRI abnormality.
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5.4. IS in the context of an immature auditory cortex
The findings of delayed auditory processing in the primary and secondary auditory cortex 
have to be interpreted in the context of a very immature auditory cortex during the first year 
of life (Moore et al, 2001; Moore, 2002). In normal developing infants axons radiate into 
the deeper layers 4, 5 and 6 of the auditory cortex only between 4 to 5 months and 1 year of 
age respectively. The process of maturation of the auditory cortex is possibly compromised 
by infantile spasms occurring between 4-8 months of age altering the dentritic and synaptic 
organization of the auditory cortex. Some evidence supporting damage of the auditory 
cortex by seizure activity is shown by electrical kindling changing the interictal temporal 
response properties of single units recorded from the primary auditory cortex in cats 
(Valentine et al, 2005).
5.5. Summary and conclusions
This is the first study showing that auditory obligatory and novelty ERPs are delayed in 
infants with IS during both wakefulness and sleep compared to normal controls. Abnormal 
auditory processing in the primary auditory cortex and also abnormal auditory detection 
support the general hypothesis that there is an abnormality of the development of the 
auditory neural network in the temporal lobe in infants with IS.
As the auditory cortex is very immature during the first years of life it is suggested that
infantile spasms may interfere with crucial maturational processes during this time period.
This may involve interference with synaptogenesis, pruning of synapses, dentritic spine
development and possible changes in neurotransmitter systems. There is also evidence from
the Landau Kleffner Syndrome, a later onset epileptic encephalopathy that the continuous
discharges are associated with atrophic superior temporal areas (Takeoka et al, 2004). If
infantile spasms are causing the delayed auditory processing one might therefore tentatively
speculate that the temporal cortices in infants with IS may also show acutely atrophic
changes, but may also appear normal due a normal number of synaptic connections which
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may not have not been incorporated into functioning units. A possible outcome may be 
therefore be a “rewired temporal lobe” which may then have forward-feeding effects onto 
the processing by further networks outside the temporal lobe with the consequences of 
abnormal cognition seen in infants with infantile spasms. Infantile spasms may result from a 
particular temporal desynchronization of several central nervous system developmental 
processes, resulting in an encephalopathy with specific seizures and a characteristic EEG 
(Frost and Hrachovy 2005)
Our model emphasises the vulnerability of the immature temporal lobe to infantile spasms 
during development in the first year of life
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CHAPTER 6: FIGURES
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Figure 1.6. Neurons, which are radially symmetric 
(1), randomly oriented (2) or asynchronously 
activated (3) do not produce externally observable 
electric or magnetic fields (Rugg 1996).
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Figure 1.7. Open field source configuration. Neurons which are non-radially symmetric, 
spatially aligned and synchronously activated add up to produce externally observable 
electric and /or magnetic fields (Rugg 1996).
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Figure 1.8. Schematic representation of potentials evoked following auditory stimulation. 
Both amplitude (pV) and latency (ms) are displayed using logarithmic scales. Potentials 
are grouped into three categories: early, middle and late (Cooper et al., 1980).
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Figure 1.9. Summary of the brain areas where P3a and P3b were found to be 
generated (Halgren et al., 1998).
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Figure 1.10. Upper part shows plots of the novelty P3 
elicited in the auditory, visual and somatosensory 
modalities in patients with lateral prefrontal or posterior 
medial temporal lesions (red lines) and matched control 
groups (blue lines). Positive is plotted upwards, Scale 
bar for the auditory and somatosensory plots Scale bar 
for the visual plots, Lower part shows topographic maps 
illustrating the scalp topography of the novelty P3 in 
two patient groups and the control group. The novelty 
P3 had a frontal topography in control subjects across 
all modalities whereas the novelty P3 topography was 
more posterior in patients with prefrontal lesions, and 
was virtually eliminated in patients with medial 
temporal lesions (Ranganath et al., 2003).
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Figure 2.1. Group mean ERPs of the components PI 50, N250, P350 and N450 in controls 
at 5-8 months and 9-14 months during wakefulness (green) and sleep (red) at electrode 
F3.
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Figure 2.2. Group mean ERPs to novel sounds at 5-8 months during wakefulness.
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Figure 2.3. Group mean ERPs to novel sounds at 5-8 months during stage sleep II.
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Figure 3.1. Group mean ERPs of the control group at 5-8 months show a MMN 
during wakefulness at electrodes C4 and M2.
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Figure 3.2. ERP of a control infant at 6 months shows a MMN during wakefulness at 
electrodes C4 and M2.
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Figure 3.3. ERP of a control infant at 7 months shows a MMN during wakefulness at 
electrodes C4 and M2.
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Figure 3.4. Group mean ERPs of the control 
group at 1 -4 months show the components 
P I50, N250 and P350 during wakefulness 
(green) and sleep (red) at electrode F3.
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Figure 3.5. The amplitudes of the P150 and 
P350 of the group mean ERPs of the control 
group at 5-8 months show an inversion of the 
polarity in wakefulness and sleep across the 
anterior-posterior axis.
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Figures 3.6 and 3.7 show the replicability of the obligatory components P I50, N250 and
P350 in 2 control infants during wakefulness in two consecutive recordings at electrode F3.
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Figure 3.8 Figure 3.9
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Figures 3.8 and 3.9 show the replicability of the obligatory components PI 50, N250 and
P350 in 2 control infants during sleep in two consecutive recordings at electrode F3.
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Figure 3.10 shows the latencies of the P I50 and P350 in control infants corrected for 
gestational age during wakefulness at electrodes F3 (•) and F4 (V).
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Figure 3.11. Group mean averaged ERPs of the 
control group at 5-8 months show an inversion of 
polarity between the N250 and P250C at electrodes 
Ml and C3 and Cz during wakefulness.
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Figure 3.12. ERP of a control infant at 4 months shows the eP250F and 1P250F at 
F4 and the inversion of polarity between the eP250F and the eN250 at P8.
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Figure 3.13. Group mean ERPs of the control group at 
9-15 months show an inversion of the Ncl at electrodes 
F3 (black) and P3 (blue) during wakefulness.
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Figure 3.14 Figure 3.15
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Figures 3.14 and 3.15 show the replicability of the novelty components N250 and P500 in
2 control infants during wakefulness in two consecutive recordings at electrode M l.
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Figure 3.16. Group mean ERPs of the control group at 
5-8 months show an inversion of polarity between the 
P250C and N250 at electrodes M 1 and C3 during stage 
II sleep.
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Figure 3.17. Group mean ERPs of the control group at 
5-8 months show an inversion of polarity between the 
P250F and N250F at electrodes F3 and P3 during stage 
II sleep.
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!Figure 3.18. Group mean ERPs of the control group at 
5-8 months show an inversion of polarity between 
P500 and NcS at electrodes Cz and M1/M2 during 
sleep.
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Figures 3.19 and 3.20 show the replicability of the novelty components N250 and P500 in
2 control infants at 6 months during sleep in two consecutive recordings at electrode M l.
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Figure 3.21. Group mean ERPs of the control groups at 1-4, 5-8 and 9-14 months show 
the N250 and P500 during wakefulness and sleep at electrode M 1.
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Figure 3.22. Group mean ERPs of the control groups at 1-4, 5-8, 9-14 months show 
the P250F at F4 during wakefulness.
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Figure 3.23 Box and whisker plots show the P500 latency at left (Ml) and right (M2) 
mastoid electrodes of the control groups at 1-4, 5-8 and 9-14 months during sleep (s) 
and wakefulness (a).
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Figure 3.24. Box and whisker plots show the fNclamplitudes of the 
control groups at 1-4, 5-8 and 9-15 months at electrode F3 during 
sleep and wakefulness.
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Figure 3.25 shows box plots of N250-CP250 peak amplitudes at 1-4, 5-8 and 9-15
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EOGH*
Figure 3.26. M oderate EEG abnorm ality during wakefulness showing widespread slowing of 
the background activity without focal signs or epileptiform  features.
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Figure 3.27. Severe EEG abnormality during wakefulness showing marked excess of slow 
activity and generalised spikes and waves.
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Figure 3.28. Moderate EEG abnormality during sleep showing K-complexes and sleep 
spindles indicating Stage 2 sleep. In addition there is an excess of slow activity for this state.
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Figure 3.29. Severe EEG abnormality during sleep showing marked slow activity and bursts 
of discharges. No normal sleep architecture is seen.
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Figure 3.30. Hypsarrhythmia during sleep.
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Figures 3.31 and 3.32 show the replicability of the P150, N250 and P350 in 2 infants with 
infantile spasms of 5-8 months during wakefulness in two consecutive recordings at 
electrode F3.
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Figure 3.34
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Figures 3.33 and 3.34 show the replicability of the PI 50 in 2 infants with infantile spasms
of 5-8 months during sleep in two consecutive recordings at electrode F3.
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Figure 3.35. Group mean ERPs show the P150, N250 and P350 at 1-4 months in controls 
(green) and infants with IS (red) during wakefulness and sleep at electrode F3.
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Figure 3.36. Group mean ERPs show the P I50, N250 and P350 at 5-8 months in controls
(green) and infants with IS during wakefulness and sleep at Electrode F3.
141
Wakefulness Sleep
•7 .5 -
N250 P350
-5 .0 - P150
•2 .5 -
pV 0 .0 -
2 .5 -
5 .0 -
P350
7 .5 - P150 N250
- 200.0  - 100.0 0.0
ms
-7 .5 -
N250
-5 .0 - P150 N250
-2 .5 -
P350
2 .5 -
5 .0 -
P350
P1507 .6 -
■200.0 -100.0 0.0 100.0 200.0 300.0 400.0 500.0 600.0 700.0
Figure 3.37. Group mean ERPs show the P I50, N250 and P350 at 9-14 months in controls
(green) and infants with IS (red) during wakefulness and sleep and electrode F3.
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Figures 3.38 and 3.39 show one infant with IS and all 3 obligatory components (P150, 
N250, P350) and one infant with IS with only one component (PI50) respectively during 
wakefulness compared to the group mean ERPs of the control group at 9-14 months.
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Figures 3.40 and 3.41 show the replicability of the novelty components N250 and P500 in 2
infants with IS of 5-8 months during wakefulness in two consecutive recordings at
electrode M l.
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Figure 3.42 Figure 3.43
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Figures 3.42 and 3.43 show the replicability of the novelty components N250 and P500 in 2 
infants with IS during sleep in two consecutive recordings at electrode M l.
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Figure 3.44 shows group mean ERPs of the N250 and P500 in controls (green) 
compared to IS (red) at 1-4 months during wakefulness and sleep at electrode M l.
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Figure 3.45 shows group mean ERPs of the N250 and P500 of controls (green)
compared to IS (red) at 5-8 months during wakefulness and sleep at electrode M l.
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Figure 3.46 shows group mean ERPs of the N250 and P500 in controls (green) compared 
to IS (red) at 9-14 months during wakefulness and sleep at electrode M l.
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Figure 3.47. shows group mean ERPs of the Ncland Nc2 in controls (green) compared to 
IS (red) at 5-8 months in wakefulness at electrode F3 and F4.
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Figure 3.48 shows a patient with IS at 10 months and a R middle cerebral territory infarct
with abnormal N250 and P500 components at electrodes M l, M2, P7 and P8 compared to
control group (9-14 months) at P7 and P8 in sleep.
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Figure 3.49 shows a patient with IS at 8 months and a R cortical dysplasia and abnormal 
N250 and P500 components at electrodes M l, P7, M2 and P8 compared to the control 
group (5-8 months) at P7 and P8 in sleep.
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CHAPTER 7: TABLES
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Table 1.1. Summary of studies on the infant obligatory auditory ERP components.
Study Subjects State Stimuli ISI Recording montage Developmental findings
(Lenard et al., 
1969)
14 full-tem 
newborns
Not stated Sine wave 
Square wave 
Female human 
voice
10-15 sec Bipolar recording 
T5-Cz, T6-Cz
N2 amplitude larger to 
square wave sounds and 
female voice than to sine 
wave sounds
(Barnet, 1975) 
Cross-sectional
130 full-term 10 
days to 37 months
Asleep
Staging
Clicks 2.5 sec Cz (vertex) referred 
to joined 
mastoids
P2-N2 complex stable in 
infants, with increasing age 
latency decreases 
significantly in stage 2 
sleep alone and also when 
all sleep stages taken 
together(P2, N2 and P3), 
complexity and amplitude 
increases
(Ohlrich et al., 
1978)
Longitudinal
16 infants 
2 weeks to three 
years
Asleep
Staging
Clicks 2.5 sec Cz (vertex) referred 
to joined 
mastoids
Similar results to the study 
by Bamet et al 1975 (Cross- 
sectional)
(Kurtzberg et 
al., 1984) 
Longitudinal
35 preterms, 17 at 
term, 1, 2 and 3 
months
Either awake 
or active 
sleep
Speech 
sounds/da/ta/ 
and simple 
tones
2.7 sec Between Fz and Cz 
(“C f’); C3 and Ml 
(“C3M “); C4 and 
M2 (“C4M”); Oz
Shift from negativity to 
positivity, with midline 
preceding lateral and full- 
terms preceding preterms
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(Shucard et al., 
1987) Cross- 
sectional
12 full-term infants 
at 1, 3 and 6 
months
Awake Sine tones 2-4 sec T3-Cz, T4-Cz Complexity and amplitude 
increase, non-significant 
latency increase
(Rotteveel et 
al., 1987) 
Cross-sectional
65 pre-term at 25- 
52 weeks at 
conceptional age
Awake, 
sleep could 
not always 
be avoided
Clicks 2 sec Active sites Cz, C4\ 
C3’
Reference A2, Al 
Ground Fz 
Derivations Cz-A2, 
Cz-Al,
C4’-A2, C3’-A1
Latency of early peaks 
decreases, adult wave form 
achieved by 3 months
(Novak et al., 
1989)
Longitudinal
32 full-terms at 
term, 18 at lm 
Mo, 14 at 2,15 at 3, 
and 6 months
Before 1 
month either 
awake or in 
active sleep, 
older infants 
awake
Speech sounds 
/da/ /ta/and 
the
corresponding
formants
2.7 sec CF, C3M, C4M, F3, 
F4, F7, F8,, C3, C4, 
T5,T6, P3,P4, Al, 
A2, (Oz)
By 3 months , ERP all sites 
predominantly positive, PI 
and N1 appear and the 
latency decreases
(Vaughan et 
al., 1992) 
Longitudinal
11 full terms: 
term to 24 months
Not stated Speech sounds 
/da/ /ta/
2.7 sec Between Fz and Cz 
(“C f’);C3 and Ml 
(“C3M “); C4 and 
M2 (“C4M”); Oz
ERP complexity increases, 
P2 amplitude maximal at 6 
months, followed by a 
decrease
(Pasman et al., 
1999)
Cross-sectional
147 infants from 
28 weeks to 14 
years
Awake, 
sleep could 
not always 
be avoided
Clicks 2 sec Active sites Cz, C4\ 
C3’
Reference A2, Al 
Ground Fz 
Derivations Cz-A2, 
Cz-Al,
C4’-A2, C3’-A1
Disintegration of ERP at 36- 
41 weeks, from 40 weeks 
until 4-6 years the P2-N2 
complex. A second 
disintegration at about 6 
years, adult like-like P60- 
N100-P170 by 6-10 years
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(Kushnerenko 
et al., 2002) 
Longitudinal
15 infants from 
birth
Awake/
active
asleep
Partial
harmonic tones
0.7 sec F3, F4, C3, C4, P3, 
P4, T3, T4 according 
to 10-20 system, 
reference R mastoid
Components identifiable at 
birth (PI 50, N250, P350, 
N450)
(Jing et al., 
2006)
Longitudinal
5 infants from 3 
months to 24 
months
awake 2 complex 
tones with 
fundamental 
frequency of 
100 or 300 Hz
0.3 sec 62 electrodes, vertex 
electrode as 
reference
PI50, N250, P350, N450 
components decreased with 
increasing age, N250 and 
P350 amplitudes reached a 
maximum at 9 months of 
age, MMN was not obvious 
at 3Mo of age, but robust at 
6 month of age
155
ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 302 (35) 296 (28) 256 (22) 254 (26)
electrodes 5-8 months 252 (27) 253 (28) 218(20) 207 (22)
F3, F4 (ms) 9-15 months 246 (51) 246 (50) 176(19) 172 (20)
Side n.s. F(l,23)=9.7 , p=0.005
Age F (2,27)= 5.4, p=0.011 F (2,23)=32.7, pcO.001
Condition F(l,22)= 22.9, p<0.001
Side F (1,22)= 5.5, p=0.031
P150 Age F (2,21)= 12.^ , p<0.001Amplitude at 1 -4 months 6.9 (6.3) 6.2 (5.0) 3.9 (2.1) 4.0 (2.1)
electrodes F3, F4 5-8 months 8.8 (5.6) 8.9 (5.5) 5.8 (1.6) 5.3 (2.0)
(li V) 9-15 months 7.7 (6.0) 8.0 (5.5) 5.7 (2.1) 6.3 (1.9)
Side n.s. n.s.
Age n.s. n.s.
Condition F (1,21)= 7.6 p=0.013
Side n.s.
Age n.s.
Table 3.2. M ean (SD) am plitude and peak latency values for the obligatory ERP
com ponent P I 50 across age groups during w akefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 373 (28) 379 (17) 373 (52) 367 (54)
electrodes 5-8 months 384 (64) 376 (50) 306 (23) 310(29)
F3, F4 (ms) 9-15 months 327 (36) 329 (33) 259(19) 258(16)
Side n.s n.s.
Age F (2,20)= 3.8 p=0.041 F (2,20)= 50.0, p<0.001
Condition F (1,15)= 13.6, p<0.004
Side n.s.
N250 Age F(2,14)= 26.5, p<0.001Amplitude at 1 -4 months -0.4 (3.1) -.52 (3.3) -0.11 (2.5) -0.11 (2.4)
electrodes F3, F4 5-8 months 1.6 (5.4) 1.7 (4.7) -0.05 (4.6) -1.3 (6.2)
(MV) 9-15 months 3.7 (3.6) 3.8 (3.7) 0.58 (2.1) 0.43 (2.5)
Side n.s. n.s.
Age n.s. n.s.
Condition n.s.
Side n.s.
Age n.s.
Table 3.3. M ean (SD) am plitude and peak latency values for the obligatory ERP
com ponent N250 across age groups during w akefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 504 (35) 493 (43) 443 (27) 445 (35)
electrodes 5-8 months 494 (70) 486 (66) 407(11) 405 (17)
F3, F4 (ms) 9-15 months 428 (27) 417(30) 340 (24) 341 (24)
Side F (1,21)= 7.10 p=0.016 n.s.
Age F (2,20)= 6.2 p=0.009 F (2,19)=26.0, pcO.OOl
Condition F (1,15)= 26.7, p<0.001
Side n.s.
P350 Age F (2,14)=114.9, pcO.OOlAmplitude at 1 -4 months 2.8 (1.9) 3.0 (2.0) 2.0 (1.7) 2.0 (1.8)
electrodes F3, F4 5-8 months 5.4 (4.0) 5.0 (3.1) 4.5 (4.6) 4.2 (4.3)
(li V) 9-15 months 6.5 (3.9) 6.6 (3.9) 3.7 (3.1) 3.8 (3.2)
Side n.s. n.s.
Age n.s. n.s.
Condition n.s.
Side n.s.
Age n.s.
Table 3.4. M ean (SD) am plitude and peak latency values for the obligatory ERP
com ponent P350 across age groups during w akefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 689(106) 670(110) 818(62) 716(110)
electrodes 5-8 months 519(18) 511 (16) 762 (87) 733 (98)
Ml, M2 (ms) 9-15 months 517(44) 520 (44) 666 (88) 539(105)
Side n.s. F (1,23)=9.9, p=0.005
Age F (2,27)= 17.1 pcO.OOl F (2,22)=6.9, pcO.OOl
Condition F (1,21)= 24.8, pcO.OOl
P500 Side F (1,21)= 7.5, p=0.014Age F (2,20)= 12.2, p=0.001
Condition x Side F (1,21)= 7.6, p=0.013
Amplitude at 1 -4 months 13.9 (6.8) 11.8 (5.6) 4.5 (4.6) 6.0 (3.1)
electrodes 5-8 months 19.3(6.9) 14.0(8.2) 9.2 (3.8) 4.9 (5.7)
Ml, M2 (pV) 9-15 months 15.4 (8.7) 13.8 (6.9) 5.9 (4.6) 4.4 (4.2)
Side F (1,28)= 4.8, p=0.037 F (1,23)=4.9 p=0.038
Age n.s. n.s;
Side x Age: F(l,23)=4.8, 
p=0.019
Condition F (1,21)= 35.1, pcO.OOl
Side F (1,21)= 7.8, p=0.012
Age n.s.
Table 3.5. Mean (SD) amplitude and peak latency values for the novelty ERP 
component P500 across age groups during wakefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 722 (99) 687 (97) 842 (37) 839 (33)
electrodes 5-8 months 567 (29) 569 (13) 816(57) 792 (54)
F3,F4 9-15 months 575 (66) 542 (74) 738 (62) 710(62)
Side F (1,24) = 17 p=0.001 n.s
Age F (2,23) = 8.9 p=0.002 n.s
Condition F (1,19) = 31.0 pcO.OOl
Side F (1,19) = 7.1 p=0.017
Ncl Age F (2,18) = 15.0 pcO.OOlAmplitude at 1 -4 months -7.5 (4.6) -8.4 (4.8) -1.9 (1.6) -2.8 (1.9)
electrodes 5-8 months -10.0 (8.8) -13 (9.2) -1.3 (4.9) -1.6 (2.5)
F3, F4 (pV) 9-15 months -8.8 (5.5) -12.6 (4.9) -2.8 (6.0) -4.9 (4.9)
Side F ( 1,24)=12.6 p=0.002 n.s
Age n.s
Condition F (1,19)=13.3 p=0.002
Side F (1,19)=13.3 p=0.002
Table 3.6. Mean (SD) amplitude and peak latency values for the novelty ERP 
component N cl across age groups during wakefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Nc2
Latency at
electrodes 
F7, F8 (ms)
1-4 months 1059(177) 1009(152) 1305 (109) 1305 (139)
5-8 months 947 (56) 907 (84 ) 1198 (106) 1217(121)
9-15 months 862 (65) 790(67 ) 1040 (70) 1002(82 )
Side n.s.
Age F (2,23)=8.5 p=0.002 F (2,19)=13.2 pcO.OOl
Condition F (1,14)= 78 p<0.001
Age F (2,13)= 39 pcO.OOl
Amplitude at
electrodes 
F7, F8 (|iV)
1 -4 months -5.2 (8.9) - 9.8 (6.0) -2.3 (1.8) -2.2 (1.5)
5-8 months -6.7 (1.5) - 4.1 (5.2) -3.8 (1.4) -4.7 (2.5)
9-15 months -4.1 (2.8) - 5.7 (2.5) -2.7 (2.4) -4.3 (2.2)
Side n.s. n.s.
Age n.s. n.s.
Condition n.s.
Table 3.7. Mean (SD) amplitude and peak latency values for the novelty ERP 
component Nc2 across age groups during wakefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
P250
Latency at
electrodes 
F3, F4 (ms)
1 -4 months 352 (71) 372 (38) 279 (62) 272 (51)
5-8 months 358 (41) 338 (57) 344 (81) 370 (92)
9-15 months 336 (50) 300 (67) 281 (84) 264 (75)
Side n.s. n.s.
Age n.s. F (2,23)=4.5, p=0.024
Condition F (1,22)=8.1, p=0.010
Side n.s.
Age n.s.
Condition x Age F (2,21)=4.1 p=0.032
Amplitude at
electrodes 
F3, F4 (pV)
1 -4 months 12.9 (4.9) 11.1 (3.6) 6.7 (3.3) 5.9 (3.4)
5-8 months 14.4 (5.6) 13.1 (6.8) 12.6 (4.1) 11.4 (3.0)
9-15 months 12.3 (7.0) 12.5 (5.8) 9.4 (5.4) 9.1 (4.2)
Side n.s. n.s.
Age n.s. F (2,23)=5.6, p=0.011
Condition F (1,22)=13.5, p=0.002
Side n.s.
Age n.s.
Table 3.8. M ean (SD) am plitude and peak latency values for the novelty ER P
com ponent P250 across age groups during w akefulness and sleep.
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ERP component
Age
group
Sleep Awake
Left Right Left Right
Latency at 1 -4 months 279 (46) 293 (61) 313 (55) 255 (67)
electrodes 5-8 months 285 (40) 263 (41) 315(57) 325 (52)
M 1, M2 (ms) 9-15 months 248 (28) 256 (32) 270 (69) 239 (59)
Side n.s. n.s.
Age n.s. n.s
Condition n.s
N250 Side n.s.Age n.s.
Amplitude at 1 -4 months -14.2 (9.6) -13.5 (6.0) -9.8 (4.6) -7.9 (3.2)
electrodes 5-8 months -13.6 (5.1) -15.9 (6.5) -16.7 (8.1) -13.2 (4.1)
Ml, M2 (pV) 9-15 months -11.5 (4.7) -10.7 (4.6) -10.5 (5.2) -6.3 (4.8)
Side n.s. F(l,24)=l l . l , i II o o o u>
Age n.s. F (2,23)= 5.2, p=0.015
Condition n.s.
Side n.s.
Age n.s.
Table 3.9. M ean (SD) am plitude and peak latency values for the novelty ER P
com ponent N250 across age groups during w akefulness and sleep.
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Table 3.10. Clinical details o f patients with infantile spasms.
NR Patient Sex Date of 
Birth
ERP at 
age (days) 
corrected for GA
DBS R
T
Seizure onset of 
infantile spasms
Seizures
before
infantile
spasms
1 AF F 15.10.00 318 N C 6.5 Mo NO
2 FB F 21.09.01 319 A S 4 Mo NO
3 MK F 22.11.01 174 A c 4.6 Mo NO
4 TM F 24.05.01 304 A c 7 Mo YES
5 EPE F 22.09.01 279 N s 6 Mo NO
6 SP F 26.09.02 121 A c 3 Mo NO
7 FT F 04.07.00 401 A c 6 Mo NO
8 AJ F 07.09.01 122 A c 3.6 Mo NO
9 RK F 13.02.01 288 A c 3 Mo YES
10 SJ F 05.10.02 214 A s 4 Mo NO
11 CB M 15.02.01 238 A c 3.6 Mo YES
12 NH M 20.07.01 211 A c 2 Mo YES
13 HH M 01.03.02 160 N s 3.6 Mo NO
14 KC M 16.08.02 200 N c 3 Mo YES
15 GK M 20.05.01 172 N c 3 Mo NO
16 MK M 16.05.01 198 N s 4 Mo NO
17 BO M 14.11.01 481 A c 3 Mo YES
18 KP M 10.10.01 50 A c 1.6 Mo NO
19 AS M 26.01.03 191 A c 2 Mo YES
20 JSE M 11.10.00 295 A c 5 Mo YES
21 MS M 25.01.02 109 N s 3 Mo YES
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22 AV M 08.11.00 369 A C 9.6 Mo NO
23 TW M 20.09.01 90 A C 2.6 Mo YES
24 AO M 10.08.01 276 A c 3 Mo YES
25 GW M 07.07.01 199 A c 5 Mo NO
26 JSH M 23.10.01 255 A c 6 Mo YES
27 JT M 29.06.03 123 A c 3.6 Mo YES
28 JB M 20.07.01 395 N c 4 Mo NO
Table 3.10. F=Female, A=Male, ERP=Event related Potential, DBS =development 
before onset of spasms, N=Normal, RT=Response to treatment, A=Abnormal, 
C=continued to have infantile spasms, S=stopped having infantile spasms, 
GA=gestational age.
Table 3.11. EEG dem ographics o f infants with IS.
NR Sex Patient State
M/S
EEG
Abnormality
Hyps
EEG more 
disorganised 
in sleep
Focal
/Multifocal-
discharges
Spasms
1 F AF A M NO NO NO
2 F FB S S YES YES MF NO
F FB A S NO MF NO
3 F MKE S s NO YES NO NO
F MKE A M NO NO NO
4 F TM S s NO YES L FOCAL NO
F TM A M NO L FOCAL NO
5 F EP S M NO NO NO NO
F EP A M NO NO NO NO
6 F SP S S YES YES MF NO
F SP A S NO MF NO
7 F FT S s NO NO MF NO
8 F AJ S s NO NO NO NO
F AJ A s NO NO NO NO
9 F RK S s NO NO MF NO
F RK A s NO N O MF YES
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10 F SJ S S NO NO R FOCAL NO
F SJ A S NO NO R FOCAL NO
11 M CB S M NO NO NO NO
M CB A M NO NO NO NO
12 M NH S S YES NO R FOCAL NO
M NH A S NO NO R FOCAL NO
13 M HH S M NO NO NO NO
M HH A M NO NO NO NO
14 M KC S S NO NO NO NO
M KC A S NO NO NO
15 M GK S s NO YES L FOCAL NO
M GK A s NO L FOCAL NO
16 M MKH S M NO NO NO NO
M MKH A M NO NO NO NO
17 M BO S M NO L FOCAL NO
18 M KP A S NO L FOCAL NO
19 M AS S M NO NO NO NO
M AS A M NO NO NO NO
20 M JSE S M NO NO NO NO
M JSE A M NO NO N O NO
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21 M MS S M NO NO L FOCAL NO
M MS A M NO NO L FOCAL NO
22 M AV S M NO NO NO NO
M AV A M NO NO NO NO
23 M TW S S NO YES L FOCAL NO
M TW A S NO L FOCAL NO
24 M AO S s NO YES MF NO
M AO A s YES NO MF NO
25 M GW S s NO NO L FOCAL NO
M GW A s NO NO L FOCAL NO
26 M JSH S s NO NO MF NO
M JSH A s NO NO MF YES
27 M JT S s NO N O MF NO
M JT A s NO N O MF NO
28 M JB S s YES YES MF NO
Table 3.11. A (awake), S (stage II sleep), F=female, M=male 
L FOCAL (L focal discharges), R FOCAL (R focal discharges), MF (multifocal 
discharges), M (Moderate EEG abnormality), S (Severe EEG 
abnormality), Hyps (Hypsarrythmia).
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Table 3.12. MRI aetiology.
Infants with infantile 
spasms
Aetiology of infantile spasms
NR Name Sex Cryptogenic Symptomatic
Normal Cortical Dysplasia Tuberous 
Sclerosis (TS)
Hypoxic 
Ischaemic (HI)
Others
l AF F Normal
2 FB F Microcephaly
Delayed
Myelination
3 MK F Trisomie 21
4 TM F TS
5 EP F Normal
6 SP F Aicardi -Syndrome
7 FT F R middle 
cerebral territory 
infarct/ L 
hemisphere 
intact
8 AJ F Lissencephaly 
Miller-Dieker Syndrome
9 RK F Proteus Syndrome/L 
hemimegalencephaly 
Gross megencehaly (also 
R side of the brain)
169
10 SJ F IVH grade II 
bilaterally 
Periventricular 
Leukomalacia
11 CB M L sylvian fissure 
abnormality
12 NH M Cortical dysplasia/ of the 
R inferior parietal lobule 
extending into the angular 
gyrus region
13 HH M Normal
14 KC M Normal
15 GK M Normal
16 MK M Normal
17 BO M TS
18 KP M L parietal cortical 
dysplasia
19 AS M HI
20 JS M Delayed 
Myeli nation
21 MS M TS
170
22 AV M Normal
23 TW M L occipital and posterior 
parietal region, L temporal 
occipital
24 AO M HI
25 GW M Delayed
Myelination
Absent
corpus
callosum
26 JSH M HI
27 JT M HI
28 JB M Normal
Table 3.12. F=female, M=male.
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Table 3.13. Amplitude of background activity of the EEG in patients 
with IS and averages used in the analysis.
Nr Patient Background 
activity (juV)
Obligatory
averages
Novel
averages
Aetiology
Sleep Awake Sleep Awake Sleep Awake
1 FA 50 1249 139 N
2 FB 75 50 1262 1664 146 204 other
3 CB 75 50 552 1223 128 139 CD
4 JB 200 75 2154 NS 255 NS N
5 NH 100 100 1292 NS 154 NS CD
6 HH 100 25 1317 1046 153 123 N
7 KC 75 75 NS 1295 134 159 N
8 MK 75 50 607 1244 72 147 other
9 GK 75 50 NS 1076 71 176 N
10 MKH 75 50 1381 NS 161 NS N
11 TM 100 50 NS 1196 71 145 TS
12 BO 150 NS 228 TS
13 KP 50 1144 215 CD
14 EP 50 25 1949 1068 231 129 N
15 SP 150 150 NS NS 163 405 CD
16 AS 50 25 1257 1043 149 202 HI
17 JSH 150 50 638 1976 76 230 HI
18 MS 50 50 1328 2020 161 229 TS
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19 FT 150 1660 198 HI
20 AV 75 25 686 1068 165 NS N
21 TW 150 200 NS 1214 71 144 CD
22 AO 100 100 NS NS NS NS HI
23 AJ 250 250 NS NS NS NS CD
24 GW 100 75 NS NS NS NS other
25 JS 75 50 NS NS NS NS other
26 RK 300 300 NS NS NS NS CD
27 JT 75 75 NS NS NS NS HI
28 SJ 75 150 NS NS NS NS HI
Table 3.13. NS= No signal, XX=The novelty signal was abnormal 
despite normal background activity, CD=cortical dysplasia, 
HI=hypoxic ischaemic, TS=tuberous sclerosis, N =normal brain 
scan, Other= see table 12 MRI Aetiology for detailed information.
Amplitude
of
background
activity
±25 pV ±50pV ±75 pV ±100pV ±200pV ±300pV
Novel ERP 
P-to-P-AM 
Awake
30pV 30pV 30pV 30pV 30pV 30pV
S/N Ratio 2.4 2.1 2.0 2.1 2 2
Number of
stimulus
repetitions
(blocks)
required
16 49 100 196 729 1600
Obligatory
ERP
P-to-P-AM
7pV 7pV 7pV 7pV 7pV 7pV
S/N Ratio 2 2 2 2 2 2
Number of
stimulus
repetitions
(blocks)
required
225 841 1849 3364 13225 29584
Table 3.14. Signal to Noise Ratio in awake infants with 
infantile spasms, S/N Ratio (signal to noise ratio), 
P-to-P-AM (peak to peak amplitude).
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Amplitude
of
background
activity
±50pV ±75 pV ±100pV ±150pV ±250pV ±300pV
Novel ERP 
P-to-P-AM 
asleep
50pV 50pV 50pV 50pV 50pV 50pV
S/N Ratio 2 2 2 2 2 2
Averages
(blocks)
required
16 36 64 162 400 576
Obligatory
ERP
P-to-P-AM
lOpV lOpV lOpV lOpV lOpV lOpV
S/N Ratio 2 2 2 2 2 2
Number of
stimulus
repetitions
(blocks)
required
400 900 1600 3600 10000 14400
Table 3.15. Signal to Noise Ratio in sleeping infants 
with infantile spasms, S/R (signal to noise ratio), 
P-to-P-AM (peak to peak amplitude).
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Component Controls
(n=30)
Infantile
Spasms
(n=26)
X2 P
P150 S 30/30 100% 13/26 50% 19.5 <0.001
P150 A 26/26 100% 13/26 50% 17.3 <0.001
N250 S 23/30 76% 5/26 19% 18.3 <0.001
N250 A 23/26 88% 9/26 34% 18.6 <0.001
P350 S 23/30 76% 6/26 23% 16.0 <0.001
P350 A 22/26 84% 9/26 34% 13.4 <0.001
Novel S 29/30 96% 16/26 61% 10.8 <0.001
Novel A 23/26 88% 11/26 42% 17.3 <0.001
Table 3.16. Presence of obligatory 
components PI50, N250 and P350 and 
novelty components in control infants during 
wakefulness (A) and sleep (S) compared to 
infants with IS.
AEP Moderate 
EEG abnormality
Severe EEG 
abnormality
P
Obligatory 
present 
Sleep (13/26) 8 (30%) 5 (19%) 0.004
Wakefulness
(14/26)
10 4 (15%) 0.005
Obligatory
absent
Sleep (13/26) 1 (3,8%) 12 (46%)
Wakefulness
(12/26)
1 (3,8%) 11 (42%)
Novel present
Sleep (19/26) 9 (34%) 10 (38%) 0.03
Wakefulness
(15/26)
9 (34%) 6 (23%) 0.02
Novel absent
Sleep (7/26) 7 (26%)
Wakefulness
(11/26)
2 (7%) 9 (34%)
Table 3.17. Presence or absence of obligatory 
and novel auditory ERPs during wakefulness 
and sleep in a moderate or severe abnormal 
EEG.
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ERP component
Infantile spasms 
Mean +/- (SD)
Controls 
Mean +/- (SD)
Spearman p-value
Sleep Awake Sleep Awake Sleep Awake Sleep Awake
N250 Latency msec 321 (95) 363 (118) 267 (33) 284 (47) 0.404 0.457 0.008 <0.001
N250 Amplitude Mv -21.4(16.6) -16.8 (6.5) -22.0 (7.3) -18.1 (8.5) 0.177 0.064 0.689 0.299
PI50 Latency msec 394 (87) 298 (95) 262 (44) 207 (38) 0.666 0.488 <0.001 <0.001
PI50 Amplitude Mv 11.0 (7.7) 4.4 (13) 7.8 (5.4) 4.7 (2.0) -.215 0.192 0.183 0.218
P500 Latency msec 692 (152) 950(193) 585 (91) 729 (74) 0.666 0.488 <0.001 <0.001
P500 Amplitude Mv 19.6(18.7) 7.7 (3.6) 14.2 (5.6) 6.5 (4.1) 0.141 0.140 0.378 0.343
NcS Latency msec 667(164) 546 (81) 0.034 <0.001
NcS Amplitude pV -15.9(13.6) -14.4 (6.1) 0.556 0.818
Ncl Latency msec In data 698(180) In data 558 (86) In data 0.672 In data <0.0001
Ncl Amplitude Kv In data -.53 (2.9) In data -.13 (2.6) In data -.150 In data 0.363
Nc2 Latency msec 1182 (220) 1156 (201) 732(143) 1164(150) 0.113 0.519 0.539 0.001
Nc2 Amplitude Kv -8.5 (5.8) -8.3 (5.9) -5.5 (3.7) -2.9 (2.4) 0.451 0.206 0.01 0.220
P2a Latency msec In data In data In data In data In data In data In data In data
P2a Amplitude 9.7 (8.0) 7.17(3.5) 12.7 (5.0) 9.3 (4.4) -.252 -.295 0.107 0.042
P2b Latency msec 494(129) 540 (252) 409 (98) 386 (91) 0.331 In data 0.040 In data
P2b Amplitude Mv 14.0(12.5) 7.0 (4.0) 10.6 (5.0) 8.8 (4.9) In data 0.100 In data 0.519
N250 Latency msec 474(178) 410(147) 354 (49) 302 (55) 0.464 0.306 0.006 0.113
N250 Amplitude Kv 4.7 (3.5) 1.4 (3.5) 2.1 (3.9) 3.2 (2.9) In data 0.352 In data 0.066
P350 Latency msec 616(219) 513 (160) 462 (60) 386 (52 ) 0.418 0.421 0.017 0.018
P350 Amplitude pV 5.9 (4.0) 3.2 (2.7) 5.3 (3.1) 3.2 (2.9) 0.094 0.153 0.608 0.429
Table 3.18. Latencies and amplitudes in infants with IS compared to control infants, 
P-values remaining significant post correction are in bold, in data=insufficient data.
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APPENDICES
Parent Information (normal controls)
DEVELOPMENT OF LANGUAGE POTENTIALS
We would like to ask your permission to include your child in this project.
The aim of the study
The aim of the study is to see whether infantile spasms, a type of epilepsy that begins in 
first year of life, can slow the children’s learning and speech. We are suggesting that this 
form of epilepsy interferes with the language centres in the brain. This may lead to new 
forms of treatment for infantile spasms.
Why is the study being done?
Babies with infantile spasms often develop difficulties with learning, speech and general 
development. This study will try to understand the way that the epilepsy causes such 
problems.
How is the study to be done?
Your baby will be admitted to the Neurology unit at Great Ormond Street Hospital to have 
an EEG (electroencephalogram). Electrodes will be attached to the head to record brain 
activity. Your baby will be seated in a safety seat and electrodes will be attached to the 
head using an elastic cap. Sounds like ta and da will be played to both ears of your child via 
speakers at a distance of 30 cm. The sound will include a bird, cat or a dog. The tests will 
take approximately 1 hour.
What are the risks and discomfort?
No risks to your child can be foreseen. There is no discomfort wearing the elastic cap with 
the electrodes on the head.
Who will have access to the case/records?
Only the researchers and a representative of the Research Ethics Committee will have 
access to the data collected during this study.
The use of some types of personal information is safeguarded by the Data Protection Act 
1998 (DPA). The DPA places an obligation on those who record or use personal 
information, but also gives rights to people about whom information is held. If you have 
any questions about data protection, contact the Data Protection Officer via the switchboard 
on 020 7405 9200 extension 5217.
What are the arrangements for compensation?
This research has been approved by an independent Research Ethics Committee who 
believe that it is of minimal risk to the child. However, research can carry unforeseen
D1
risks and you are informed of your rights in the unlikely event that any harm should occur 
as a result of taking part in this study.
No special compensation arrangements have been made for this project but you have the 
right to claim damages in a court of law. This will require you to prove a fault on the part 
of the Hospital and/or any manufacturer involved.
What are the potential benefits?
This study will not bring any immediate benefits to your child. However if we can show 
that the temporal lobe of the brain is affected in children with infantile spasms, it may be 
possible in the future to protect the temporal lobe in children with infantile spasms and 
prevent developmental delay.
Do I have to take part in this study?
If you decide, now or at a later stage, that you do not wish to participate in this research 
project, that is entirely your right and will not in any way prejudice any present or future 
treatment.
Who do parents speak to if problems arise?
If you have any complaints about the way in which this research project has been, or is 
being conducted, please, in the first instance, discuss them with the researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via the Research and Development 
Office, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, or if urgent, by 
telephone on 020 7905 2620 and the Committee administration will put you in contact with 
him.
Researcher who will have contact with the family
Dr Klaus Werner, Honorary Research Fellow, Neurosciences Unit, The Wolfson 
Centre.Professor Brian Neville, Professor of Paediatric Neurology, GOSH
Details of how to contact the researcher
The Wolfson Centre, Mecklenburgh Square, London WC1N 2AP 
Tel: 020 7837 7618
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REC No. 01NR05
Great Ormond Street Hospital for Children NH S Trust and Institute 
o f  Child Health Research Ethics Committee
Consent Form for PARENTS OR GUARDIANS 
of Children Participating in Research Studies
Title: Mechanisms for cognitive impairment in the syndrome of infantile spasms and other 
early-onset epilepsies.
NOTES FOR PARENTS OR GUARDIANS
1. Your child has been asked to take part in a research study. The person organising that 
study is responsible for explaining the project to you before you give consent.
2. Please ask the researcher any questions you may have about this project, before you 
decide whether you wish to participate.
3. If you decide, now or at any other stage, that you do not wish your child to participate in 
the research project, that is entirely your right, and if your child is a patient it will not in 
any way prejudice any present or future treatment.
4. You will be given an information sheet which describes the research project. This 
information sheet is for you to keep and refer to. Please read it carefully.
5. If you have any complaints about the way in which this research project has been or is 
being conducted, please, in the first instance, discuss them with your researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via The Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London WC1N 1EH 
or if urgent, by telephone on 020 7905 2620 and the committee administration will put 
you in contact with him.
CONSENT
I/We__________________________ , being the parent(s)/guardian)s) of
______________________________  agree that the Research Project named above has
been explained to me to my/our satisfaction, and I/We give permission for our child to take
part in this study. I/We have read both the notes written above and the Information Sheet
provided, and understand what the research study involves.
SIGNED (Parent(s)/Guardian(s)) DATE
SIGNED (Researcher) DATE
REC No. 01NR05
REC No. 01NR05
NOTES FOR THE RESEARCHER
It is your responsibility to ensure that the parents/guardians and child (it mature enough) 
understand what the research project involves, both theoretically and practically. You must 
allow sufficient time to do this. You must make the judgement of whether or not the child 
can understand the project. Age alone is not important. Make sure that the relatives or 
child can contact you if they have additional questions.
A copy of this completed form must be placed in the patient’s clinical records and a copy 
must be kept by you with the research records.
If there are any unforeseen ethical problems with this study you must inform the Chairman 
of the Research Ethics Committee immediately (via The Research and Development Office, 
ICH on 0171 905 2620) and follow this up in writing.
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Parent Information (infantile spasms)
THE EFFECT OF INFANTILE SPASMS ON THE 
DEVELOPMENT OF LANGUAGE
We would like to ask your permission to include your child in this project.
The aim of the study
The aim of the study is to see whether infantile spasms, a type of epilepsy that begins in 
first year of life, can slow the children’s learning and speech. We are suggesting that this 
form of epilepsy interferes with the language centres in the brain. This may lead to new 
forms of treatment for infantile spasms.
Why is the study being done?
Babies with infantile spasms often develop difficulties with learning, speech and general 
development. This study will try to understand the way that the epilepsy causes such 
problems.
How is the study to be done?
Your baby will be admitted to the Neurology unit at Great Ormond Street Hospital to have 
an EEG (electroencephalogram). Electrodes will be attached to the head to record brain 
activity. Your baby will be seated in a safety seat and electrodes will be attached to the 
head using an elastic cap. Sounds like ta and da will be played to both ears of your child via 
speakers at a distance of 30 cm. The sound will include a bird, cat or a dog. The tests will 
take approximately 1 hour.
What are the risks and discomfort?
No risks to your child can be foreseen. There is no discomfort wearing the elastic cap with 
the electrodes on the head.
Who will have access to the case/records?
Only the researchers and a representative of the Research Ethics Committee will have 
access to the data collected during this study.
The use of some types of personal information is safeguarded by the Data Protection Act 
1998 (DPA). The DPA places an obligation on those who record or use personal 
information, but also gives rights to people about whom information is held. If you have 
any questions about data protection, contact the Data Protection Officer via the switchboard 
on 020 7405 9200 extension 5217.
What are the arrangements for compensation?
This research has been approved by an independent Research Ethics Committee who 
believe that it is of minimal risk to the child. However, research can carry unforeseen
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risks and you are informed of your rights in the unlikely event that any harm should occur 
as a result of taking part in this study.
No special compensation arrangements have been made for this project but you have the 
right to claim damages in a court of law. This will require you to prove a fault on the part 
of the Hospital and/or any manufacturer involved.
What are the potential benefits?
This study will not bring any immediate benefits to your child. However if we can show 
that the temporal lobe of the brain is affected in children with infantile spasms, it may be 
possible in the future to protect the temporal lobe in children with infantile spasms and 
prevent developmental delay.
Do I have to take part in this study?
If you decide, now or at a later stage, that you do not wish to participate in this research 
project, that is entirely your right and will not in any way prejudice any present or future 
treatment.
Who do parents sneak to if problems arise?
If you have any complaints about the way in which this research project has been, or is 
being conducted, please, in the first instance, discuss them with the researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via the Research and Development 
Office, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, or if urgent, by 
telephone on 020 7905 2620 and the Committee administration will put you in contact with 
him.
Researcher who will have contact with the family
Dr Klaus Werner, Honorary Research Fellow, Neurosciences Unit, The Wolfson Centre. 
Professor Brian Neville, Professor of Paediatric Neurology, GOSH
Details of how to contact the researcher
The Wolfson Centre, Mecklenburgh Square, London WC1N 2AP 
Tel: 020 7837 7618
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Great Ormond Street Hospital for Children NHS Trust and Institute 
o f Child Health Research Ethics Committee
Consent Form for PARENTS OR GUARDIANS 
of Children Participating in Research Studies
Title: Mechanisms for cognitive impairment in the syndrome of infantile spasms and other 
early-onset epilepsies.
NOTES FOR PARENTS OR GUARDIANS
6. Your child has been asked to take part in a research study. The person organising that 
study is responsible for explaining the project to you before you give consent.
7. Please ask the researcher any questions you may have about this project, before you 
decide whether you wish to participate.
8. If you decide, now or at any other stage, that you do not wish your child to participate in 
the research project, that is entirely your right, and if your child is a patient it will not in 
any way prejudice any present or future treatment.
9. You will be given an information sheet which describes the research project. This 
information sheet is for you to keep and refer to. Please read it carefully.
10. If you have any complaints about the way in which this research project has been or is 
being conducted, please, in the first instance, discuss them with your researcher. If the 
problems are not resolved, or you wish to comment in any other way, please contact the 
Chairman of the Research Ethics Committee, by post via The Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London WC1N 1EH 
or if urgent, by telephone on 020 7905 2620 and the committee administration will put 
you in contact with him.
CONSENT
I/We__________________________ , being the parent(s)/guardian)s) of
_______________________________  agree that the Research Project named above
has been explained to me to my/our satisfaction, and I/We give permission for our child to
take part in this study. I/We have read both the notes written above and the Information
Sheet provided, and understand what the research study involves.
SIGNED (Parent(s)/Guardian(s)) DATE
SIGNED (Researcher) DATE
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NOTES FOR THE RESEARCHER
It is your responsibility to ensure that the parents/guardians and child (it mature enough) 
understand what the research project involves, both theoretically and practically. You must 
allow sufficient time to do this. You must make the judgement of whether or not the child 
can understand the project. Age alone is not important. Make sure that the relatives or 
child can contact you if they have additional questions.
A copy of this completed form must be placed in the patient’s clinical records and a copy 
must be kept by you with the research records.
If there are any unforeseen ethical problems with this study you must inform the Chairman 
of the Research Ethics Committee immediately (via The Research and Development Office, 
ICH on 0171 905 2620) and follow this up in writing.
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Clinical assessment of infants with IS Appendix 3
Name
DB______________________________________________
Age at investigation (ERP) in days
Time from first seizure to ERPs
Age onset of first seizure____________________________
First seizure description
Age onset of IS
Subsequent seizures after ERP description 
Response to treatment
Seizure frequency prior to administration of AEDs per week
Which AED before ERP 
When ERP
Which AED afterwards
Developmental Delay prior to IS
Developmental Delay during IS/ cognitive regression
MR!
EEG
Visual alertness____________________________________
Metabolic investigations
Infectious scren____________________________________
Underlying diagnosis
Follow up ______________________________________
Seizure free
Appendix 4
SEQUENCE OF STIMULI
AAAAAAAAA CAAAAA CAAANAAAAAANAAAAA CAAAAN 
A CAAAA CAANAAANAAA CAAAAA CNAAAAAAAAANAA 
ANAAA CAAANAAAAAAAAAANA CAA CAAANA CAAANA 
ANAAAA CNAAAAAANNAAAAAAAAAAAANAA CAAAAA C 
ANAANAAAA CAA CAAAAAAAAN CAAAAAAAAANA CAA 
AAAAA CAAAANAANAAAA CAAAANAAAAAANAA CAAAA 
A CAAANAAAAAAAAAAAN CAAAAAA CANAAA CAAAAA 
AAA CAAAAN CAAAAAAAAAAA CAAAANCAAAAAANAAA 
AAANAAA CAA CAAAAN CAAAAAAAAA CANAAAA CAA 
AAAAAAANAANAAA CAAAAAAAAA CAAANAAAAN CAA 
CAANAAANANAA CAAAANAAAAAA CAAANAAAA CAAAA 
AAANAAA CAANAAAAAAAAAA CAAAAA CAAANAAAAAA 
NAAAAA CAAAANA CAAAA CAANAAANAAA CAAAAA C 
NAAAAAAAAANAA CAAA CAAANAAAAAAAAAAANA CAA 
N CAAANA CAAANAANAAAA CNAAAAAN CAAAAAAAAA 
AAANAA CAAAAA CANAANAAAA CAA CAAAAAAAAN C 
AAAAAAAAANA CAAAAAAA CAAAANAANAAAA CAAAAN 
AAAAAANAA CAAAAA CAAANAAAAAAAAAAAN CAAAAA 
CANAAA CAAAAAAAA CAAAANA CAAAAAAAAAAA CA 
AAANCAAAAAANAAAAAANAAA CNAA CAAAAN CAAAAA 
AAAA CANAAAA CAAAAAAAAANAANAAA CANAAAA CA 
AANAAAAN CAAACAANAAAANAA CAAAANAAAAAA CAA 
ANAAAA CAAAAAAANAAA CAAN
The identical sequence was used in all recordings 
A=standard, B=pre-deviant, C=deviant, N=novel stimulus
